12TH AFRICAN ROTAVIRUS

12TH AFRICAN ROTAVIRUS

REPORTON THE

A DECADE OF ROTAVIRUS VACCINATION IN AFRICA

EMPERORS PALACEJOHANNESBURG

SAVING LIVES AND CHANGING THE FACE OF DIARRHOEAL DISEASE

30, 31 JULY &1 AUGUST

ORGANISERS AND SPONSORS:

SPONSORS:

CONTENTSPREAMBLE 2

SYMPOSIUM THEME 3

OBJECTIVES 3

SYMPOSIUM SPONSORS 3

INTERNATIONAL SCIENTIFIC ADVISORY COMMITTEE 4

LOCAL ORGANISING COMMITTEE 4

SECRETARIAT 5

SYMPOSIUM DELEGATES 5

SYMPOSIUM DELEGATE SPONSORSHIP 6

REGISTRATION AND ABSTRACTS 6

SCIENTIFIC PROGRAMME SESSIONS AND PRESENTATIONS 6

SYMPOSIUM SPECIAL SESSION 7

POST EVENT METRICS FROM APP 7

SYMPOSIUM EVALUATION RESULTS 7

ANNEXURE A: 12th ARS LIST OF DELEGATES 12

ANNEXURE B: LIST OF DELEGATES BY ORGANISATION 30

ANNEXURE C: 12TH ARS - ABSTRACT REVIEW FORM 34

ANNEXURE D: 12TH ARS PROGRAMME 35

ANNEXURE E: CONSOLIDATED INCOME AND EXPENDITURE REPORT 41

2

12TH AFRICAN ROTAVIRUSA DECADE OF ROTAVIRUS VACCINATION IN AFRICA

EMPERORS PALACEJOHANNESBURG

SAVING LIVES AND CHANGING THE FACE OF DIARRHOEAL DISEASE

30, 31 JULY &1 AUGUST

PREAMBLE

The 12th African Rotavirus Symposium (ARS) was held at the Emperors Palace Convention Centre (https://www.emperorspalace.com/conferences-and-events/conference-overview) in Johannesburg, South Africa, from 30th July 2019 to the 1st August 2019. It was hosted by the South African Medical Research Council (SAMRC) (www.mrc.ac.za). The symposium coincided with the 20th anniversary of the African Rotavirus Network (AfrRN) and the 50th anniversary of the SAMRC.

This biennial event - organised under the auspices of the AfrRN - has over the years grown from a half-day symposium to now a 3-day global event as it continues to shape the agenda of rotavirus research and prevention globally, attracting key international opinion leaders in diarrheal diseases. The AfrRN is a regional network of institutions conducting research on paediatric diarrhoeal diseases in collaboration with the World Health Organisation African Regional Office (WHO AFRO), Ministries of Health and other partners.

The AfrRN began in 1998 in response to the need to address diarrhoeal disease, which was a continental disease that was under-researched in Africa. In particular, there was a crucial need to determine rotavirus burden of disease, the diversity of circulating strains, and increase awareness around rotavirus disease in Africa. The first ARS was held in South Africa in 2000 and since then several more symposia were held in several African countries. The previous two meetings were held in Lilongwe, Malawi in 2017 and in Bamako, Mali in 2015.

The ARS series is aimed at bringing African rotavirus researchers, policy-makers, clinicians, public health practitioners and health officials together to share ideas, expertise and learning across organizations and countries in the areas of rotavirus vaccine introduction, vaccine impact and diarrhoeal disease prevention and control in Africa. The AfrRN also established the African Rotavirus Surveillance Network (AfrRSN) in 1999 to conduct research to facilitate evidence-based decision making on the introduction of rotavirus vaccines in the African region and to create a platform to study the impact of the rotavirus vaccine on diarrhoea post-introduction. The AfrRSN is a regional network of institutions and Ministries of Health conducting core surveillance on diarrhoeal diseases in children, which depends entirely on effective National Surveillance Programmes. The WHO AFRO (Congo, Brazzaville) currently coordinates the AfrRSN.

3REPORT ON THE 12TH AFRICAN ROTAVIRUS SYMPOSIUM 2019

SYMPOSIUM THEME

The theme of the 12th ARS was:

“A decade of rotavirus vaccination in Africa – Saving lives and changing the face of

diarrhoeal disease”

OBJECTIVES

The key objectives of the 12th ARS were:• Review and share global epidemiological trends on rotavirus diarrhoea.• Share progress and experiences on rotavirus vaccine introduction, impact and safety monitoring in African

countries.• Enable networking for research, academia and career growth among rotavirus researchers and program

implementers.• Review and shape agenda for research/surveillance on other diarrhoeal pathogens.

SYMPOSIUM SPONSORS

The symposium was sponsored by the following organisations:• World Health Organisation (WHO)• Bill & Melinda Gates foundation (BMGF), USA• South African Medical Research Council (SAMRC), South Africa• PATH, USA• Centers for Diseases Control and Prevention (CDC), USA• GlaxoSmithKline (GSK), Belgium• Bharat Biotech International (BBI) Ltd, India• Serum Institute of India (SII)

4 REPORT ON THE 12TH AFRICAN ROTAVIRUS SYMPOSIUM 2019

INTERNATIONAL SCIENTIFIC ADVISORY COMMITTEE

The members of the symposium International Scientific Advisory Committee (ISAC) are shown in Table 1.

Table 1: Members of the 12th ARS International Scientific CommitteeName Organisation Country

Dr Duncan Steele (Chair) BMGF USA

Prof Jeffrey Mphahlele SAMRC South Africa

Dr Jason Mwenda WHO AFRO Congo

Dr George Armah Noguchi Memorial Institute for Medical Research (University of Ghana) Ghana

Dr Clint Pecenka PATH USA

Dr Khuzwayo Jere Malawi-Liverpool-Wellcome Clinical Research Programme, University of Malawi

Malawi

Dr Jacqueline Tate US Centers for Disease Control and Prevention (CDC), Atlanta USA

Prof Fredrick Were University of Nairobi Kenya

Prof Amorissani Folquet University Center of Cocody and President of the Association of African Pediatric Societies

Côte d’Ivoire

Dr Carl Kirkwood BMGF USA

Dr Umesh Parashar CDC Atlanta USA

Dr Debbie Atherly PATH USA

LOCAL ORGANISING COMMITTEE

The members of the symposium Local Organising Committee (LoC) are shown in Table 2.

Table 2: Members of the 12th ARS Local Organising Committee Name Organisation Country

Prof Jeffrey Mphahlele (Symposium Chair)

SAMRC South Africa

Prof Mapaseka Seheri Sefako Makgatho Health Sciences University South Africa

Prof Nicola Page National Institute for Communicable Diseases, a Division of the National Health Laboratory Services

South Africa

Dr Pieter Bos Formerly from Sefako Makgatho Health Sciences University South Africa

Dr Jason Mwenda WHO AFRO Congo

Dr George Armah Noguchi Memorial Institute for Medical Research (University of Ghana) Ghana

Dr Khuzwayo Jere Malawi-Liverpool-Wellcome Clinical Research Programme, University of Malawi

Malawi

Dr Michelle Groome University of the Witwatersrand South Africa

Dr Martin Nyaga University of the Free State South Africa


SECRETARIAT

The members of the symposium Secretariat are shown in Table 3.

Table 3: Members of the 12th ARS SecretariatName Organisation Country

Dr Niresh Bhagwandin SAMRC South Africa

Ms Arlene Smith SAMRC South Africa

Ms Mandy Salomo SAMRC South Africa

Ms Kefiloe Masemola SAMRC South Africa

SYMPOSIUM DELEGATES

Three-hundred and twenty-seven (327) delegates registered to participate in the symposium. Of these, 277 attended. Delays in obtaining visas and/or late visa applications were/was the primary reason for the no show.

Annexure A contains the list of the delegates by name, organization, email address, country, delegate and sponsorship.

A list of delegates from 40 countries (excluding 7 delegates whose name of country was not captured) participated in the symposium. The delegates by country is shown in Figure 1:

Figure 1: Number of delegates by country

The list of delegates by institution is shown in Annexure B.

NUMBER OF DELEGATES BY COUNTRY70

37

62

9421113

61132

12

611

47

2

171313

11231

89

3538

156

14

7

60

50

40

30

20

10

0

Afg

hani

stan

Bel

giu

mB

enin

Bo

tsw

ana

Bur

kina

Fas

oC

amer

oo

nC

entr

al A

fric

an A

fric

anC

ong

oC

ôte

d’Iv

oire

Dem

ocr

atic

Rep

ublic

of C

ong

oD

enm

ark

eSw

atin

iEt

hio

pia

Gam

bia

Gha

naIn

dia

Ken

yaM

adag

asca

rM

alaw

iM

ali

Mau

ritan

iaM

oro

cco

Mo

zam

biq

ueN

iger

iaPa

kist

anPa

lest

ine

Rwan

da

Sene

gal

Sout

h A

fric

aSw

itzer

land

Tanz

ania

The

Net

herla

nds

Tog

oTu

nisi

aU

gan

da

Uni

ted

Kin

gd

om

USA

Zam

bia

Zim

bab

we

Unk

now

n

Gab

on


SYMPOSIUM DELEGATE SPONSORSHIP

Sponsorship was made available to delegates, mainly those from African countries. The sponsorship included symposium attendance, return economy class flights, single occupancy accommodation and meals for the duration of the conference.

In total, 119 delegates were funded from sponsorship monies as indicated in Annexure A.

REGISTRATION AND ABSTRACTS

The call for registration opened on 26 February 2019 and closed on 13 May 2019. However, several late registrations were accepted.

Abstracts were invited in the subject areas shown below. In order to get a good balance of presentations for each subject area, delegates were requested to select up to 3 subject areas (sub-themes) that best categorized their research.

One-hundred and seventy-three (173) abstracts were received as follows:• Epidemiology and disease burden (100)• Molecular epidemiology of rotavirus strains (66)• Implementation of vaccines in Africa (75)• Vaccine development and safety (35)• Vaccine policy in Africa (25)• Health economics of rotavirus (14)• Advances in rotavirus research (46)• Understanding diarrheal pathogens in Africa (51)• Virology/strain diversity (65)• New rotavirus vaccines and approaches to vaccination (34)• The abstracts were collected and divided among the ISAC members, who reviewed it, scored it (score sheet

attached – Annexure C) and recommended an oral or poster presentation.

SCIENTIFIC PROGRAMME SESSIONS AND PRESENTATIONS

Oral scientific presentations were made in the sessions listed below:• Rotavirus burden of disease and epidemiology in Africa• Understanding diarrhoeal disease and enteric pathogens in Africa• Molecular epidemiology and rotavirus strain diversity in Africa• Rotavirus vaccine implementation in Africa• Rotavirus vaccine development updates• Scientific advances in rotavirus research in Africa• The economic and public health impact of rotavirus vaccines in Africa• Vaccine policy and decision-making in Africa

There were 39 oral scientific presentations and 139 poster presentations.


SYMPOSIUM SPECIAL SESSION

A special session was included in the symposium programme to celebrate the Rotavirus Network 20th anniversary and the 50th anniversary of the SAMRC. The theme of the session was:

“A decade of rotavirus vaccination in Africa”

The panelists in this session were Dr Joe Phaahla (Deputy Minister of Health, SA), Glenda Gray (SAMRC), Duncan Steele (BMGF), Jason Mwenda (WHO AFRO), Veronica Denti (GAVI), George Armah (AfrRN) and Yin Yin Aung (UNICEF). The panel was moderated by Dr Michael Mol.

The overall objectives of the panel discussion were: i. To build on the previous successes of accelerating rotavirus vaccine introduction in the remaining Africa

countries and beyond ii. To highlight major achievements of the African Rotavirus Network in the last 20 years iii. To strengthen collaboration in the field of vaccination and exchange best immunisation practices amongst key

stakeholders iv. To support key advocacy strategies of improving childhood vaccination coverage in Africa.

POST EVENT METRICS FROM APP

The app vendor provided the following snapshot of the “big numbers” from the app as at 13 Aug 2019: • Users – Total number of unique uses across devices - 181• All Engagement – Total number of actions across all users taken with the app (i.e. sessions, speakers,

exhibitors… etc.) – 6.41k• User Contributors – Total number of attendee messages and social shares – 1.16k• Minutes Open – Total time spent in minutes, users used the app – 5.83k• Navigation Icon Taps – Total number of taps for all navigation icons – 3.76k

Based on the app metrics section of the Event Center, the vendor was very pleased to see “how the app did onsite” and indicated that the above “numbers are a testament to the event’s organisers marketing tactics and fantastic efforts promoting downloads before and during the event”.

SYMPOSIUM EVALUATION RESULTS

The feedback from delegates via the app is shown below. There were 45 valid responses.


Figure 2: Evaluation of the scientific programme

Figure 5: Evaluation of the symposium app

Figure 3: Evaluation of the symposium management

Figure 4: Evaluation of the symposium venue

EVALUATION RESULTS OF SCIENTIFIC PROGRAMME

Overall rating of oral presentations

Overall rating of poster presentations

Rating of the overall conference programme

Were the session topics and discussion valuable?

Was the overall programme format useful in providing opportunities for engaging with others?

Were the sessions useful in terms of providing new knowledge?

Excellent Good Average Poor

EVALUATION RESULTS OF SCIENTIFIC PROGRAMME

Did you upload the app onyour tablet or mobile phone?

Was the App application useful and informative?

Did you receive the app notifications?

Yes No

EVALUATION RESULT OF SYMPOSIUM MANAGEMENT

What is your rating of the overall event management?


EVALUATION RESULT OF SYMPOSIUM VENUE

Rating on conference venue


0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

53%

98%

98%

73%

76%

55%

44%

65%

35%

73%

93%

45%

25%

22%

41%

49%

28%

58%

27%

7%

7%

7%

7%

2%

2%

2%

2%

2%

4%


The challenges experienced by delegates are shown in Table 4.

Table 4: Challenges experienced by delegatesChallenges experienced # of occurences

No (includes None, N/A, Anything, None at all, Nothing particularly) 25

Language (includes Translator) 2

The hotel kept us for more than 3 hours before check in. 1

Positioning of screens for prenters & place lab top by the podium (sic) 1

Reimbursement should be in US dollars to avoid loss of value for money used by delegates 1

Hard to find where lunch and dinner were - more info/map would have been good 1

The improvements suggested by delegates for future events are shown in Table 5.

Table 5: Improvements suggested for future eventsImprovements suggested for future events # of occurences

None (includes ‘No need to improve just keep it up’, ‘Keep it up’, ‘All was well’, ‘Keep it up’, ‘Everything was on top’, ‘Done’))

8

Translation 4

Prof Jeff and team are wonderful. I ask them to be ready to mentor next host so that at worst to be like the SA symposium

1

Poster presentation can be programmed like daily 1

Pharmaceutical companies should be challenged to invest in African reasearch and to support Africa to develop and produce local products

1

Less food 1

Conserve this highest level if préparation ans management, put all of communications on the plateforme (sic)

1

Start planing early at least 1.5 years in advance 1

Pharmaceuticals and industry players for vaccines being introduced should not fund the Symposium to avoid Bias and influencing output

1

If funds are available, conference bags, carpet on stage 1

An additional session on basic science would be nice 1

Perhaps have some form of mentorship programme for young scientists 1




AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATES

No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

1D

rM

oha

mm

edA

bd

ulka

dir

Uni

vers

ity o

f Ilo

rin T

each

ing

H

osp

ital

Nig

eria

do

cmo

hng

@g

mai

l.co

m

Ye

sPo

ster

2D

rK

ham

is A

liA

bei

dM

inis

try

of H

ealth

, Zan

zib

arTa

nzan

iakh

aab

eid

@ya

hoo

.co

m

BB

IYe

s

3D

rA

dic

ato

u-La

i Ad

éola

A

do

ukè

Ad

eoth

yRa

vin/

JSI

Ben

inad

ouk

e25@

gm

ail.c

om

Yes

4M

rJi

joho

Mis

chae

l M

iche

l E.

Ag

bla

Nat

iona

l Lab

ora

tory

of

Pub

lic H

ealth

, Ben

inB

enin

mic

kam

ail2

1@ya

hoo

.fr

WH

OYe

sPo

ster

5D

rC

hant

alA

geb

mab

iese

No

guc

hi M

emo

rial I

nstit

ute

for M

edic

al R

esea

rch,

U

nive

rsity

of G

hana

Gha

nach

agb

em@

gm

ail.c

om

Yes

Ora

l

6D

rC

harle

sA

go

tiK

EMRI

K

enya

cnya

igo

ti@ke

mri-

wel

lco

me.

org

Yes

Post

er

7D

rM

oha

med

Lem

ine

Ahm

edM

inis

try

of H

ealth

Mau

ritan

iale

min

e198

7@ho

tmai

l.fr

BM

GF

Yes

Post

er

8D

rM

lan

Alic

e Pa

tric

ia

Lab

ora

tory

C

ôte

d’Iv

oire

alic

ebrit

oh@

yaho

o.fr

Yes

Post

er

9D

rM

ajd

oul

ine

Am

esle

kU

nive

rsity

Mo

ham

med

VM

oro

cco

mej

do

ulin

12@

gm

ail.c

om

SI

IYe

s

10Pr

of

Am

ah M

adel

eine

A

mo

rissa

ni F

olq

uet

Uni

vers

ity C

ente

r of

Co

cod

y an

d P

resi

den

t of

the

Ass

oci

atio

n o

f Afr

ican

Pe

dia

tric

So

ciet

ies

Cô

te d

’Ivo

ire

SII/

BM

GF

Yes

11D

rA

lber

ta A

mu

Am

uD

od

ow

a H

ealth

Res

earc

h C

entr

eG

hana

alb

erta

.am

u@g

mai

l.co

m

PATH

Yes

12D

rJo

hnA

nder

son

Rese

arch

Co

nsul

tant

USA

jdan

der

soni

v@g

mai

l.co

m

Ye

sO

ral

13M

rN

eel

And

hee-

Shah

Rese

arch

Co

nsul

tant

Sout

h A

fric

aN

And

hee-

Shah

@as

pen

pha

r-m

a.co

m

Ye

s

14M

rTo

nda

Loha

ndjo

laA

ndre

John

Sno

w, I

ncD

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

and

re_t

ond

a@cd

.jsi.c

om

Yes

Post

er

15D

rB

oul

aA

ngel

ine

Yvet

te

Crs

cenc

eW

orld

Hea

lth O

rgan

izat

ion

Cam

ero

on

bo

ulaa

yc@

yaho

o.fr

B

MG

FYe

sPo

ster


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

16D

rPe

ace

No

nyel

um

Ani

edu

Dep

t of P

aed

iatr

ics,

C

hukw

uem

ake

Od

umeg

wu

Oju

kwu

Uni

vers

ity T

each

ing

H

osp

ital (

CO

OU

TH)

P.M

.B

5022

Nig

eria

pp

and

mer

cy@

gm

ail.c

om

B

BI

No

17D

rC

apo

Chi

chi A

mo

isso

uA

nnic

k El

ono

reSu

ru L

ere

Ho

spita

l B

enin

mar

war

68@

yaho

o.fr

W

HO

Yes

Post

er

18D

rPa

lwas

haA

nwar

iSe

lf em

plo

yee

Afg

hani

stan

anw

ari2

22@

gm

ail.c

om

PA

THYe

sO

ral

19M

rB

erna

rdA

rhin

Ko

mfo

Ano

kye

Teac

hing

H

osp

ital (

KA

TH)

Gha

nab

arhi

nn@

gm

ail.c

om

Yes

20Pr

of

Geo

rge

Arm

ahN

og

uchi

Mem

oria

l Ins

titut

e fo

r Med

ical

Res

earc

h,

Uni

vers

ity o

f Gha

na

Gha

naG

Arm

ah@

nog

uchi

.ug

.ed

u.g

h

PATH

Yes

21D

rEr

nest

Asa

reYa

le S

cho

ol o

f Pub

lic H

ealth

U

nite

d S

tate

s M

ino

r Out

lyin

g

Isla

nds

erne

st.a

sare

@ya

le.e

du

N

oPo

ster

22D

rD

ebo

rah

Ath

erly

PATH

USA

dat

herly

@p

ath.

org

Yes

23D

rA

ntho

ny O

yovw

ikig

hoA

timat

iU

nive

rsity

of B

enin

Tea

chin

g

Ho

spita

lN

iger

iato

nyat

imat

i@ya

hoo

.co

m

BB

IYe

s

24D

rIs

iaka

Ayo

dej

i

Yes

25H

iba

A

zrag

Fed

eral

Min

istr

y o

f Hea

lthhi

baa

zrag

@g

mai

l.co

m

PATH

/B

MG

F Ye

s

26M

rsC

ons

tanc

e A

zub

uike

U

nive

rsity

of N

iger

ia

Teac

hing

Ho

spita

lN

iger

iaaz

ubui

keco

nsta

nce@

gm

ail.

com

SI

IN

oPo

ster

27D

rJu

liaB

aker

Emo

ry U

nive

rsity

USA

julia

.bak

er@

emo

ry.e

du

Ye

sPo

ster

28D

r B

akun

awa

Gar

ba

Bel

loB

akun

awa

Nat

iona

l Prim

ary

Hea

lth

Car

e D

evel

op

men

t Ag

ency

Nig

eria

gar

ba.

bak

unaw

a@np

hcd

a.g

ov.

ng

PATH

No

29M

sA

ssan

ato

u

Bam

og

oJo

hns

Ho

pki

ns U

nive

rsity

B

loo

mb

erg

Sch

oo

l of P

ublic

H

ealth

USA

abam

og

o1@

jhu.

edu

Ye

sPo

ster

30M

rsV

irgin

ieB

ang

a M

ing

o

Inst

itut P

aste

ur d

e B

ang

uiC

entr

al A

fric

an

Rep

ublic

virg

inie

.ban

gue

@ya

hoo

.fr

Ye

sPo

ster

31D

rSo

uro

u H

ono

ré

Ban

kole

Yes

32D

rA

mad

ou

Bar

ryG

SKN

iger

iaam

ado

u.x.

bar

ry@

gsk

.co

m

No

33M

rsC

hio

ma

Ben

jam

inp

uja

Uni

vers

ity o

f Nig

eria

Te

achi

ng H

osp

ital

Nig

eria

chio

map

uja@

yaho

o.c

om

B

BI

No

Post

er

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

34D

rB

ernd

Ben

ning

hoff

GSK

Pha

rmac

eutic

als

Bel

giu

mB

ERN

D.X

.BEN

NIN

GH

OFF

@G

SK.C

OM

Yes

35D

rN

iresh

B

hag

wan

din

SAM

RCSo

uth

Afr

ica

nire

sh.b

hag

wan

din

@m

rc.

ac.z

a B

MG

F Ye

s

36D

rN

iranj

anB

hat

PATH

USA

nbha

t@p

ath.

org

Yes

37D

rJo

sep

h B

iey

Wo

rld H

ealth

Org

aniz

atio

nB

urki

na F

aso

Ye

s

38M

rSi

mo

ne S

alva

do

rB

oen

eN

atio

nal I

nstit

ute

of H

ealth

Mo

zam

biq

uesi

mo

nbo

ene@

gm

ail.c

om

B

BI/

B

MG

FYe

sO

ral

39Pr

of

Cat

herin

eB

oni

Uni

vers

ity F

elix

Ho

upho

uet

Bo

igny

Ab

idja

nC

ôte

d’Iv

oire

bo

nica

tc@

yaho

o.fr

G

SK

Yes

Post

er

40M

rN

agar

aju

Bo

nig

aB

hara

t Bio

tech

Inte

rnat

iona

l Lt

dIn

dia

nag

araj

u363

2@b

hara

tbio

-te

ch.c

om

Yes

41D

rIs

ido

reB

onk

oun

go

uU

nive

rsity

Oua

ga1

Pr J

ose

ph

KI Z

EBO

Bur

kina

Fas

oo

uind

gue

ta@

gm

ail.c

om

G

SK

Yes

Post

er

42M

sSi

ob

han

Bo

twrig

htW

orld

Hea

lth O

rgan

izat

ion

Switz

erla

ndb

otw

right

s@w

ho.in

t

Yes

43D

rM

icha

el D

om

inic

B

ow

enC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAm

kb6@

cdc.

go

v

Yes

44D

rW

elek

azi

Bo

yce

GSK

Sout

h A

fric

aw

elek

azi.x

.bo

yce@

gsk

.co

m

Ye

s

45D

rRa

chel

Mar

iaB

urke

Cen

ters

for D

isea

se C

ont

rol

and

Pre

vent

ion

USA

Yes

46M

sEl

eano

rB

urne

ttC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAw

wg

7@cd

c.g

ov

Ye

sPo

ster

47D

rJo

sep

hine

Bw

og

iU

gan

da

Viru

s Re

sear

ch

Inst

itute

Ug

and

ajb

wo

gi@

uvri.

go

.ug

B

MG

F Ye

sPo

ster

48M

rFr

eder

ick

Joel

C

asse

lsPA

THU

SAfc

asse

ls@

pat

h.o

rg

Ye

s

49M

rB

rian

Cas

tro

Jo

hn S

now

, Inc

USA

bria

n_ca

stro

@js

i.co

m

Ye

s

50M

rTy

ler

Cha

vers

Cen

ters

for D

isea

se C

ont

rol

and

Pre

vent

ion

USA

mkv

9@cd

c.g

ov

Ye

s

51D

rRi

char

dC

haw

ana

Bio

vac

Sout

h A

fric

ach

awan

a.ric

hard

@g

mai

l.co

m

Ye

s

52M

r G

ideo

n K

ipko

rir

Che

lule

UN

ICEF

Sup

ply

Div

isio

nD

enm

ark

gch

elul

e@un

icef

.org

Yes

53D

rTh

om

as

Che

rian

Wo

rld H

ealth

Org

aniz

atio

nSw

itzer

land

tche

rian5

4@g

mai

l.co

m

Ye

s

54M

sJo

rfel

iaC

hila

ule

Inst

ituto

Nac

iona

l de

Saúd

e (IN

S), M

oza

mb

ique

Mo

zam

biq

uejo

rfel

iach

ilaul

e@g

mai

l.co

m

BM

GF

Yes

Post

er

55D

rRo

ma

Chi

leng

iC

entr

e fo

r Inf

ectio

us

Dis

ease

Res

earc

h in

Zam

bia

Za

mb

iaro

ma.

chile

ngi@

cid

rz.o

rg

PATH

Yes

Post

er


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

56D

rM

asuz

yoC

hirw

aC

entr

e fo

r Inf

ectio

us

Dis

ease

Res

earc

h in

Zam

bia

Zam

bia

suzy

o.c

hirw

a@g

mai

l.co

m

PATH

Yes

57D

rC

aro

line

Cle

op

atra

Chi

seng

aC

entr

e fo

r Inf

ectio

us

Dis

ease

Res

earc

h in

Zam

bia

Zam

bia

caro

line.

chis

eng

a@ci

drz

.org

G

SKYe

sPo

ster

58M

rA

ssuc

enio

C

hiss

aque

Nat

iona

l Ins

titut

e o

f Hea

lth,

Mo

zam

biq

ueM

oza

mb

ique

assu

ceny

oo

@g

mai

l.co

m

SII/

BM

GF

Yes

Post

er

59D

rG

od

y Je

an

Chr

yso

sto

me

C

entr

al A

fric

an

Rep

ublic

Yes

60D

rC

hine

du

Chu

kwub

ike

WH

O s

upp

ort

ed R

ota

viru

s Se

ntin

el S

ite E

nug

u N

iger

iaN

iger

iach

ined

umb

c@ya

hoo

.co

m

WH

OYe

sPo

ster

61D

rA

ndre

wC

lark

LSH

TMU

nite

d K

ing

do

man

dre

w.c

lark

@ls

htm

.ac.

uk

Ye

sO

ral

62M

sA

lliso

nC

liffo

rdPA

THU

SAac

liffo

rd@

pat

h.o

rg

Ye

s

63D

rA

dam

Co

hen

Wo

rld H

ealth

Org

aniz

atio

nSw

itzer

land

Yes

Ora

l

64D

rM

arg

aret

Co

rtes

eC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAm

cro

tese

@cd

c.g

ov

Ye

sPo

ster

65D

rM

a O

uatt

ara

Co

ulib

aly

Ye

s

66D

rO

mar

C

oul

ibal

yM

inis

try

of H

ealth

Mal

i

Ye

s

67D

rSt

anle

y C

ryz

PATH

USA

scry

z@p

ath.

org

Yes

68Pr

of

Nig

elC

unlif

feU

nive

rsity

of L

iver

po

ol

Uni

ted

Kin

gd

om

nig

elc@

liver

po

ol.a

c.uk

Yes

69M

r Jo

hn F

red

eric

kD

adzi

eG

hana

Hea

lth S

ervi

ceG

hana

jfdad

zie@

yaho

o.c

o.u

k

Yes

70D

rSu

san

Afu

aD

aman

kaN

og

uchi

Mem

oria

l Ins

titut

e fo

r Med

ical

Res

earc

h,

Uni

vers

ity o

f Gha

na

Gha

nasd

aman

ka@

nog

uchi

.ug

.ed

u.g

h SI

IYe

sPo

ster

71 D

rA

lho

usse

ini

Dao

uda

Ho

pita

l Nat

iona

l Nia

mey

N

iger

Nia

mey

amd

145@

yaho

o.fr

No

72D

rU

jjwal

De

ICA

R-IV

RIIn

dia

ujjw

ald

e@g

mai

l.co

m

N

o

73N

ilsa

De

Deu

sIn

stitu

to N

acio

nal d

e Sa

úde

(INS)

, Mo

zam

biq

ueM

oza

mb

ique

ndeu

s1@

yaho

o.c

om

Yes

74M

rFr

eder

icD

ebel

lut

PATH

Switz

erla

ndfd

ebel

lut@

pat

h.o

rg

Ye

sO

ral

75M

rA

mad

uD

ele

WH

ON

iger

iad

elea

mad

u@g

mai

l.co

m

BB

IN

oPo

ster

76D

rSh

ola

Mo

lem

od

ileD

ele

Olo

wu

Clin

ton

Hea

lth A

cces

s In

itiat

ive

Nig

eria

sho

lam

ole

@g

mai

l.co

m

N

oPo

ster

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

77D

rFr

anci

s Ek

ow

Den

nis

No

guc

hi M

emo

rial I

nstit

ute

for M

edic

al R

esea

rch,

U

nive

rsity

of G

hana

Gha

nafd

enni

s@no

guc

hi.u

g.e

du.

gh

BM

GF

Yes

Post

er

78M

rsVe

roni

caD

enti

GA

VISw

itzer

land

vden

ti@g

avi.o

rg

Ye

sO

ral

79M

sB

ethe

l Dag

nach

ewD

eres

saB

hara

t Bio

tech

Inte

rnat

iona

l Lt

dIn

dia

bet

hel2

2@b

hara

tbio

tech

.co

m

Ye

s

80D

rSa

jjad

AD

esai

Seru

m In

stitu

te o

f Ind

ia

Priv

ate

Lim

ited

Ind

iasa

jjad

.des

ai@

seru

min

stitu

te.

com

Yes

81D

rA

mad

ou

Dio

pA

lber

t Ro

yer P

aed

iatr

ic

Ho

spita

l Lab

ora

tory

Se

neg

alam

ado

udio

pla

ba@

yaho

o.fr

G

SKYe

sPo

ster

82M

rD

ido

Dis

eng

om

oka

Cen

tre

Ho

spita

lier d

e K

ing

asan

iD

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

dis

eng

om

oka

@g

mai

l.co

m

BB

IN

oPo

ster

83D

r C

eles

teD

ona

toM

urd

och

Chi

ldre

n’s

Rese

arch

Inst

itute

A

ustr

alia

cele

ste.

do

nato

@m

cri.e

du.

au

N

o

84D

r Ib

rahi

ma

Dua

rra

MO

H M

ali

No

85D

rRa

ches

Ella

Bha

rat B

iote

ch In

tern

atio

nal

Ltd

USA

ella

r@b

hara

tbio

tech

.co

m

Ye

sPo

ster

86M

iss

Ng

ah C

arin

eE

njeh

Uni

vers

ity o

f Yao

und

e 1

Cam

ero

on

ngah

28ca

rine@

gm

ail.c

om

No

Ora

l

87Pr

of

Chi

ka C

hris

tab

elE

nwer

onu

-Lar

yea

Uni

vers

ity o

f Gha

na M

edic

al

Scho

ol

Gha

nach

ikal

arye

a@ya

hoo

.co

m

N

o

88D

rEs

ang

bed

o D

oro

thy

Om

ono

Ed

erio

nE

sang

bed

o

Nig

eria

Imm

uniz

atio

n Te

chni

cal A

dvi

sory

Gro

up

(NG

I-TA

G)

Nig

eria

eder

ie@

hotm

ail.c

om

PA

THYe

s

89D

rM

athe

w D

Eso

naC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAm

di4

@cd

c.g

ov

Ye

sPo

ster

90D

rB

ertil

laE

zeo

nwu

Fed

eral

Med

ical

Cen

ter

Asa

ba

Nig

eria

ber

tilla

.eze

onw

u@np

mcn

.ed

u.ng

Yes

Post

er

91D

rLe

eFa

irlie

Wits

Rep

rod

uctiv

e H

ealth

an

d H

IV In

stitu

te (W

ITS

RHI)

So

uth

Afr

ica

lfairl

ie@

wrh

i.ac.

za

Ye

sO

ral

92Pr

of

Imen

eFo

dha

Uni

vers

ity H

osp

ital S

ahlo

ulTu

nisi

aim

enef

od

ha@

yaho

o.fr

G

SKYe

sPo

ster

93D

rB

ete

Fran

ck H

ilaire

Mo

H B

enin

Ben

infb

ete@

yaho

o.fr

or

fbet

e@g

ouv

.bj

Ye

s

94D

rA

sied

u-B

eko

eFr

ankl

inD

epar

tmen

t of t

he G

hana

H

ealth

Ser

vice

Gha

na

Ye

s


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

95M

sM

ary

Gal

oIn

stitu

te o

f Prim

ate

Rese

arch

Ken

yain

gas

ian@

yaho

o.c

om

B

MG

F Ye

sPo

ster

96D

rSa

njay

G

and

hiG

SK B

iolo

gic

als

Ind

iasa

njay

.t.g

and

hi@

gsk

.co

m

Ye

s

97D

rB

irgitt

eG

iers

ing

Wo

rld H

ealth

Org

aniz

atio

nSw

itzer

land

gie

rsin

gb

@w

ho.in

t B

MG

F Ye

s

98M

rJo

shua

Gik

ony

oTh

e Te

chni

cal U

nive

rsity

of

Ken

yaK

enya

jng

iko

nyo

@g

mai

l.co

m

GSK

Ye

sPo

ster

99D

rFa

tima

Giw

aG

iwa

Ahm

adu

Bel

lo U

nive

rsity

Te

achi

ng H

osp

ital,

Shik

a Za

ria

Nig

eria

drf

atim

agiw

a70@

gm

ail.c

om

Yes

100

Dr

Rog

er

Gla

ss

Fog

arty

Inte

rnat

iona

l C

ente

r, N

atio

nal I

nstit

utes

o

f Hea

lth

USA

ro

ger

.gla

ss@

nih.

go

v

Ye

s

101

Dr

Ione

laG

oua

ndjik

a N

ée

Vasi

lach

eIn

stitu

t Pas

teur

de

Ban

gui

Cen

tral

Afr

ican

Re

pub

licig

oua

ndjik

a@g

mai

l.co

m

WH

OYe

s

102

Pro

fN

icho

las

Gra

ssly

Imp

eria

l Co

lleg

e Lo

ndo

nU

nite

d K

ing

do

m n

.gra

ssly

@im

per

ial.a

c.uk

Yes

103

Dr

Mic

helle

Gro

om

eRe

spira

tory

and

Men

ing

eal

Path

og

ens

Rese

arch

Uni

t, W

its

Sout

h A

fric

ag

roo

mem

@rm

pru

.co

.za

Ye

s

104

Dr

Ng

oie

Mw

amb

aG

uilla

ume

Exp

and

ed P

rog

ram

on

Imm

uniz

atio

nD

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

gui

llaum

eng

oie

mw

amb

a@g

mai

l.co

m

Ye

s

105

Mr

Fasi

l Tes

hag

erH

aile

mar

iam

Wo

rld H

ealth

Org

aniz

atio

nEt

hio

pia

TESH

AG

ERF@

WH

O.IN

T

Yes

Post

er

106

Dr

Ben

jam

inH

allo

wel

lC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAN

NV8

@cd

c.g

ov

Ye

sPo

ster

107

Mr

Ko

ne

Ham

ido

uIm

mun

izat

ion

pro

gra

mm

eC

ôte

d’Iv

oire

drk

one

ham

ido

u@g

mai

l.co

m

WH

OYe

sPo

ster

108

Dr

Vane

ssa

Cat

herin

eH

arris

Am

ster

dam

Inst

itute

fo

r Glo

bal

Hea

lth a

nd

Dev

elo

pm

ent,

Uni

vers

ity o

f A

mst

erd

am

The

Net

herla

nds

v.c.

harr

is@

amc.

uva.

nl

Ye

s

109

Pro

fW

illia

mH

ausd

orf

fPA

THU

SAb

illha

usd

orf

f@ho

tmai

l.co

.uk

Ye

sPo

ster

110

Mr

Jaym

eH

erb

ert

No

rth

Wes

t Uni

vers

itySo

uth

Afr

ica

jaym

e.he

rber

t@o

utlo

ok.

com

B

MG

F Ye

sPo

ster

111

Dr

Mus

aH

ind

iyeh

Car

itas

Bab

y H

osp

ital

Pale

stin

ehi

ndiy

eh@

yaho

o.c

om

PA

THYe

sPo

ster

112

Dr

Dia

a O

. H.H

jaija

Hja

ijaM

inis

try

of H

ealth

Pal

estin

e Pa

lest

ine

pm

dm

oh@

yaho

o.c

om

PA

THYe

s

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

113

Dr

M. J

ahan

gir

Ho

ssai

nM

edic

al R

esea

rch

Co

unci

l U

nit T

he G

amb

ia a

t the

Lo

ndo

n Sc

hoo

l of H

ygie

ne

Tro

pic

al M

edic

ine

Gam

bia

jho

ssai

n@m

rc.g

m

PATH

Yes

Post

er

114

Mr

Mar

noH

uyze

rsN

ort

h W

est U

nive

rsity

Po

tche

fstr

oo

m B

ioch

emis

try

dep

.

Sout

h A

fric

ag

erno

.huy

zers

@g

mai

l.co

m

BM

GF

Yes

Ora

l

115

Za

kou

Idd

eH

ôp

ital N

atio

nal d

e N

iam

ey

Nig

er

zako

uid

de@

yaho

o.fr

No

116

Mr

Sam

erJa

br

Pale

stin

ian

Min

istr

y o

f H

ealth

Pale

stin

esm

rjab

r@ya

hoo

.co

m

PATH

Yes

Post

er

117

Dr

Okw

o-B

ele

Jean

-Mar

ieSe

rum

Inst

itute

of I

ndia

Pr

ivat

e Li

mite

dIn

dia

okw

ob

elej

@g

mai

l.co

m

Ye

s

118

Dr

Uw

iman

aJe

anni

neK

igal

i Uni

vers

ity T

each

ing

H

osp

ital

Rwan

da

jean

nine

uw@

gm

ail.c

om

G

SK

Yes

119

Dr

Khu

zway

oJe

reM

alaw

i Liv

erp

oo

l Wel

lco

me

Trus

t Clin

ical

Res

earc

h Pr

og

ram

me

Mal

awi

Khu

zway

o.J

ere@

liver

po

ol.

ac.u

k B

MG

F Ye

sO

ral

120

Bao

min

g J

iang

Jian

gC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAb

xj4@

cdc.

go

v

Yes

121

Ms

Sio

bha

n Jo

hnst

one

Nat

iona

l Ins

titut

e fo

r C

om

mun

icab

le D

isea

ses

& U

nive

rsity

of t

he

Witw

ater

sran

d S

cho

ol o

f Pu

blic

Hea

lth

Sout

h A

fric

asi

ob

hanj

sa@

gm

ail.c

om

Yes

122

Pro

f El

ieK

abre

Dire

cteu

r Gén

éral

Po

int

foca

l du

Lab

ora

toire

de

réfé

renc

e Ro

tavi

rus

Bur

kina

Fas

oel

ie.k

abre

@g

mai

l.co

m

Ye

s

123

Dr

Man

dib

élé

Kam

Péd

iatr

e, c

oo

rdo

nnat

eur

du

site

Ro

ta d

e l’h

ôp

ital

péd

iatr

ique

Bur

kina

Fas

oka

mm

adi@

yaho

o.fr

Yes

124

Ms

Susa

n K

amal

izen

i M

inis

try

of H

ealth

eSw

atin

i eS

wat

ini

susa

nkam

aliz

eni@

yaho

o.c

om

No

125

Dr

Aro

x K

amng

’ona

Uni

vers

ity o

f Mal

awi,

Co

lleg

e o

f Med

icin

eM

alaw

iaw

kam

ngo

na@

med

col.m

w

PATH

Yes

126

Dr

Cris

oin

K

azad

i

Yes


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

127

Ad

ama

Mam

by

Kei

taC

ente

r fo

r Vac

cine

D

evel

op

men

t M

ali

PA

THYe

s

128

Mr

Sam

my

Kha

gay

iK

EMRI

Ken

yask

hag

ayi@

kem

ricd

c.o

rg

BB

IYe

sO

ral

129

Dr

Ibra

him

Kha

lilU

nive

rsity

of W

ashi

ngto

nU

SAik

halil

@uw

.ed

u B

MG

F N

o

130

Evel

yne

Nki

rote

K

imat

hiIn

stitu

te o

f Prim

ate

Rese

arch

Ken

yaev

lynk

im19

@g

mai

l.co

m

BM

GF

Yes

131

Dr

Car

l K

irkw

oo

dB

MG

H

USA

carl.

kirk

wo

od

@g

ates

foun

da-

tion.

org

Yes

132

Mr

Nic

hola

sK

iulia

Ken

ya In

stitu

te o

f Prim

ate

Rese

arch

USA

nick

.kiu

lia@

gm

ail.c

om

SI

IYe

sPo

ster

133

Dr

N’z

ue

Ko

fiW

HO

Co

untr

y o

ffice

C

ôte

d’Iv

oire

nzue

k@w

ho.in

t

Ye

s

134

Pro

fK

aren

Ko

tloff

Uni

vers

ity o

f Mar

ylan

d

Scho

ol o

f Med

icin

eU

SAkk

otlo

ff@so

m.u

mar

ylan

d.e

du

Ye

sO

ral

135

Pro

fD

ibi B

ertin

Ko

uam

eM

inis

ter o

f Hea

lth. T

each

ing

ho

spita

l of Y

op

oug

on

Ab

idja

n . D

epar

tmen

t of

ped

iatr

ic s

urg

ery

Cô

te d

’Ivo

ireko

uad

b@

yaho

o.fr

W

HO

Yes

Post

er

136

Ms

Ayb

uke

Ko

yunc

uC

entr

e fo

r Inf

ectio

us

Dis

ease

Res

earc

h in

Zam

bia

Zam

bia

Ayb

uke.

Ko

yunc

u@ci

drz

.org

B

BI

Yes

Ora

l

137

Mr

Ad

amK

uca

Uni

vers

ity o

f Pre

toria

Sout

h A

fric

a u

1402

7250

@tu

ks.c

o.z

a

Yes

138

Mrs

Yvo

nne

Mut

om

bo

Kum

wim

ba

Cen

tre

for I

nfec

tious

D

isea

se R

esea

rch

in Z

amb

iaZa

mb

iayv

onne

.kum

wim

ba@

cid

rz.o

rg

BM

GF

Yes

Post

er

139

Ms

Sand

raLa

mb

ert

The

Bio

vac

Inst

itute

Sout

h A

fric

asa

ndra

@b

iova

c.co

.za

Ye

s

140

Mr

Jero

nim

o

Lang

aN

atio

nal I

nstit

ute

of H

ealth

M

oza

mb

ique

Mo

zam

biq

uela

ngaj

ero

nim

o@

gm

ail.c

om

Yes

Post

er

141

Ms

Bel

ind

aLa

rtey

No

guc

hi M

emo

rial I

nstit

ute

for M

edic

al R

esea

rch,

U

nive

rsity

of G

hana

Gha

nab

lart

ey@

nog

uchi

.ug

.ed

u.g

h B

MG

F Ye

sPo

ster

142

Mis

sC

hris

telle

Bel

erhe

ine

Laur

eIS

TM K

insh

asa

Dem

ocr

atic

Re

pub

lic o

f the

C

ong

o

c.b

eler

hein

e.sa

co@

gm

ail.

com

SI

IN

oPo

ster

143

Dr

Nam

adi M

uham

mad

Law

alN

atio

nal P

rimar

y H

ealth

C

are

Dev

elo

pm

ent A

gen

cyN

iger

ia

nam

adi.l

awal

i@np

hcd

a.g

ove

.ng

Yes

144

Mr

Pier

reLe

Ro

uxN

ort

h W

est U

nive

rsity

Sout

h A

fric

ap

ierr

eler

101@

gm

ail.c

om

B

MG

F Ye

s

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

145

Mr

Ana

nias

Lesh

aban

aSe

fako

Mak

gat

ho H

ealth

Sc

ienc

es U

nive

rsity

Sout

h A

fric

ale

shab

ana.

anan

ias@

gm

ail.

com

Yes

Post

er

146

Pro

fB

enja

min

Ala

nLo

pm

anRo

llins

Sch

oo

l of P

ublic

H

ealth

Em

ory

Uni

vers

ityU

SAb

enja

min

.ala

n.lo

pm

an@

emo

ry.e

du

N

o

147

Dr

Mar

ie P

aul

Lusi

nga

Mat

umo

naH

op

ital P

edia

triq

ue d

e K

alem

be

Lem

be

Dem

ocr

atic

Re

pub

lic o

f the

C

ong

o

mp

lusi

nga@

gm

ail.c

om

No

Post

er

148

Mis

sJa

ime

Mac

Do

nald

NIC

DSo

uth

Afr

ica

jaim

em@

nicd

.ac.

za

Ye

sPo

ster

149

Ms

Shin

gai

M

achi

ngai

dze

Euro

pea

n D

evel

op

ing

C

oun

trie

s C

linic

al T

rials

Pa

rtne

rshi

p

Sout

h A

fric

aM

achi

ngai

dze

@ed

ctp

.org

Yes

Ora

l

150

Dr

Sani

Mal

amM

ado

Ab

uth

Zaria

Nig

eria

sani

mad

o@

yaho

o.c

o.u

k

Yes

Post

er

151

Ms

No

nkul

ulek

o

Mag

agul

aSe

fako

Mak

gat

ho H

ealth

Sc

ienc

es U

nive

rsity

Sout

h A

fric

aN

onk

ulul

eko

.mag

agul

a@sm

u.ac

.za

Ye

s

152

Dr

Clif

f Ab

dul

M

agw

iraSe

fako

Mak

gat

ho H

ealth

Sc

ienc

es U

nive

rsity

Sout

h A

fric

acm

agw

ira@

gm

ail.c

om

Yes

153

Dr

Din

aM

aham

ba

Uni

vers

ity o

f Do

do

ma

Tanz

ania

din

amah

amb

a@g

mai

l.co

m

GSK

Yes

Post

er

154

Dr

Mo

rena

M

akho

ana

Bio

vac

Sout

h A

fric

am

ore

na@

bio

vac.

co.z

a

Yes

155

Mis

sC

hiko

ndi

Mal

amb

aM

alaw

i Liv

erp

oo

l Wel

lco

me

Trus

t Clin

ical

Res

earc

h Pr

og

ram

me

Mal

awi

cmal

amb

a@m

lw.m

w

GSK

Yes

Ora

l

156

Mr

Jona

than

Man

do

loM

alaw

i Liv

erp

oo

l Wel

lco

me

Trus

t Clin

ical

Res

earc

h Pr

og

ram

me

Mal

awi

jman

do

lo@

med

col.m

w

BM

GF

Yes

Post

er

157

Dr

Inac

ioM

and

om

and

oC

entr

o d

e In

vest

igac

ao e

m

Saud

e d

e M

anhi

caM

oza

mb

ique

inac

io.m

and

om

and

o@

man

-hi

ca.n

et

SII/

BM

GF

No

Ora

l

158

Dr

Jane

tM

ans

Uni

vers

ity o

f Pre

toria

Sout

h A

fric

a ja

net.

man

s@up

.ac.

za

Ye

s

159

Mr

Mes

fin T

efer

aM

anya

zew

alEt

hio

pia

n Pu

blic

Hea

lth

Inst

itute

Et

hio

pia

mes

fin_0

7@ya

hoo

.co

m

Ye

sPo

ster

160

Mrs

Gug

uM

apha

lala

Min

istr

y o

f Hea

lth

eSw

atin

ig

pm

aph@

gm

ail.c

om

B

MG

F Ye

sPo

ster

161

Mrs

Sop

hia

Mar

ais

Uni

vers

ity o

f the

Fre

e St

ate

Sout

h A

fric

aSo

veij.

mar

ais0

5@g

mai

l.co

m

BM

GF

Yes

162

Mr

Step

hane

M

artin

GSK

Sout

h A

fric

ast

epha

ne.x

.mar

tin@

gsk

.co

m

Ye

s

163

Ms

No

sip

ho

Mat

heb

ula

GSK

Bel

giu

mN

OSI

PHO

.M.M

ATH

EBU

LA@

GSK

.CO

M

Ye

s


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

164

Dr

Den

nis

Maz

ing

iU

nive

rsity

of Z

imb

abw

eZi

mb

abw

ed

enni

s.m

azin

gi@

gm

ail.c

om

G

SK

Yes

Post

er

165

Ms

Laet

itia

Mb

ang

u B

itolo

Lu

zolo

GSK

Bel

giu

mLA

ETIT

IA.X

.MB

AN

GU

@G

SK.

CO

M

Yes

166

Mis

sA

kach

iM

bo

gu

Clin

ton

Hea

lth A

cces

s In

itiat

ive

Nig

eria

am

bo

gu@

clin

tonh

ealth

ac-

cess

.org

No

167

Mr

Dam

ien

McG

uire

GSK

Bel

giu

mD

AM

IEN

.P.M

CG

UIR

E@G

SK.

CO

M

Ye

sPo

ster

168

Ms

Sim

bul

ele

Md

lele

niU

nive

rsity

of t

he

Witw

ater

sran

d

Sout

h A

fric

aso

md

lele

ni@

gm

ail.c

om

Yes

169

Dr

Shai

lesh

Meh

taG

SK V

acci

nes,

Bel

giu

mB

elg

ium

shai

lesh

.i.m

ehta

@g

sk.c

om

Yes

170

Mr

Cha

ndM

ehta

Clin

ton

Hea

lth A

cces

s In

itiat

ive

UK

cmeh

ta@

clin

tonh

ealth

ac-

cess

.org

Yes

171

Mr

Serg

ioM

end

es d

os

Ram

os

Uni

vers

ity o

f the

Fre

e St

ate

Sout

h A

fric

ase

rgio

men

des

.do

sram

os@

gm

ail.c

om

B

MG

F Ye

sPo

ster

172

Mr

Chi

mw

emw

eM

hang

oM

alaw

i Liv

erp

oo

l Wel

lco

me

Trus

t Clin

ical

Res

earc

h Pr

og

ram

me

Mal

awi

cmha

ngo

@m

lw.m

w

BM

GF

Yes

Post

er

173

Ms

No

nhla

nhla

Cyn

thia

M

hlo

ngo

Fu

ture

hand

sSo

uth

Afr

ica

nonh

lanh

la72

@g

mai

l.co

m

Ye

s

174

Dr

Faus

taM

icha

elM

inis

try

of H

ealth

Tan

zani

aTa

nzan

ialil

_fau

@ho

tmai

l.co

m

N

oPo

ster

175

Mr

Thab

iso

M

iya

Uni

vers

ity o

f the

W

itwat

ersr

and

So

uth

Afr

ica

4887

44@

stud

ents

.wits

.ac.

za

Ye

sPo

ster

176

Mrs

Kar

abo

M

lam

bo

Dep

artm

ent o

f Sci

ence

and

Te

chno

log

ySo

uth

Afr

ica

Kar

abo

.Mla

mb

o@

dst

.go

v.za

Yes

177

Mr

Milt

on

Tshi

dis

oM

og

ots

iU

nive

rsity

of t

he F

ree

Stat

eSo

uth

Afr

ica

tmo

go

tsi1

6@g

mai

l.co

m

BM

GF

Yes

Post

er

178

Dr

Fort

unat

eM

oko

ena

Ana

tech

Sout

h A

fric

afo

rtun

ate@

anat

ech.

co.z

a

Yes

Post

er

179

Mrs

Mar

gar

etM

oko

man

eN

atio

nal H

ealth

Lab

ora

tory

Bo

tsw

ana

baf

anam

arg

aret

@g

mai

l.co

m

Ye

sPo

ster

180

Dr

Sung

sil

Mo

on

Cen

ters

for D

isea

se C

ont

rol

and

Pre

vent

ion

USA

smo

on@

cdc.

go

v

Yes

Post

er

181

Pro

fEv

ans

Mp

abal

wan

iU

nive

rsity

Tea

chin

g

Ho

spita

lsZa

mb

iaev

ansm

wila

@g

mai

l.co

m

Ye

sPo

ster

182

Pro

f Je

ffrey

M

pha

hlel

eSA

MRC

Sout

h A

fric

aje

ffrey

.mp

hahl

ele@

mrc

.ac.

za

BM

GF

Yes

183

Dr

Cat

herin

eM

uend

oM

bag

athi

Co

unty

Ho

spita

lK

enya

cart

hynm

@g

mai

l.co

m

BB

IYe

sPo

ster

184

Ms

Mak

wal

ete

Eth

elM

ufam

ade

Sefa

ko M

akg

atho

Hea

lth

Scie

nces

Uni

vers

ity

Sout

h A

fric

am

akw

alet

e@g

mai

l.co

m

Ye

sPo

ster

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

185

Mr

DA

vid

Mug

isha

Min

istr

y o

f Hea

lth U

gan

da

Ug

and

am

ugis

ha_d

avid

2@ya

hoo.

com

Yes

Post

er

186

Dr

Juliu

s N

dira

ngu

Mug

wer

uU

nive

rsity

of E

mb

uK

enya

ndira

ngu.

juliu

s@em

bun

i.ac

.ke

SII

No

Post

er

187

Dr

Muh

amm

ed A

bd

ul-

One

Am

ina

Muh

amm

ed A

bd

u-O

neN

atio

nal P

rimar

y H

ealth

C

are

Dev

elo

pm

ent A

gen

cyN

iger

iasl

imla

wi@

yaho

o.c

om

amin

a.m

uham

med

@np

hcd

a.g

ov.

ng

PATH

No

188

Dr

Julia

naM

uiva

Ken

yatt

a N

atio

nal H

osp

ital

Ken

yajm

mg

itob

u@liv

e.co

m

N

oPo

ster

189

Ms

Hild

a A

ngel

a M

ujur

uU

nive

rsity

of Z

imb

abw

eZi

mb

abw

e as

ad.a

li@ak

u.ed

u B

MG

F Ye

s

190

Mr

Arn

old

M

ukar

atirw

aM

inis

try

of H

ealth

and

Chi

ld

Car

e Zi

mb

abw

eam

ukar

atirw

a@ya

hoo

.co

m

BM

GF

Yes

191

Dr

Oliv

ier

Muk

uku

Hig

her I

nstit

ute

of M

edic

al

Tech

niq

ues

of L

ubum

bas

hiD

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

oliv

ierm

ukuk

u@ya

hoo

.fr

BB

IYe

sPo

ster

192

Mr

Jean

M

ukw

ela

Kin

gas

ani H

osp

ital C

ente

rD

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

j.muk

wel

a.sa

co@

gm

ail.c

om

B

BI

No

Post

er

193

Mr

Sand

eep

Cha

rud

atta

M

ulay

Mul

aySe

rum

Inst

itute

of I

ndia

Pr

ivat

e Li

mite

dIn

dia

sand

eep

.mul

ay@

seru

min

sti-

tute

.co

m

Ye

s

194

Ms

Ben

ilde

Mun

lela

Nat

iona

l Hea

lth In

stitu

te

Mo

zam

biq

ueB

enild

eant

nio

@g

mai

l.co

m

BM

GF

Yes

Post

er

195

Dr

And

rew

Mun

yalo

M

usyo

ki

Sout

h A

fric

an V

acci

natio

n an

d Im

mun

izat

ion

Cen

ter

(SA

VIC

)

Sout

h A

fric

ap

amus

yoki

@g

mai

l.co

m

Ye

s

196

Mr

Jere

mia

h K

imat

hiM

utua

ruch

iuSt

uden

t Tec

hnic

al U

nive

rsity

Ken

yaje

reki

mat

hi@

gm

ail.c

om

SI

I/B

MG

F Ye

s

197

Dr

Mer

cyM

vund

ura

PATH

USA

mm

vund

ura@

pat

h.o

rg

Ye

s

198

Mr

Mik

eM

wan

ga

KEM

RI

Ken

yam

mw

ang

a@ke

mri-

wel

lco

me.

org

Yes

Post

er

199

Mr

Pete

rM

wan

gi

Uni

vers

ity o

f the

Fre

e St

ate

Nex

t Gen

erat

ion

Seq

uenc

ing

Uni

t

Sout

h A

fric

ant

hig

apet

e@g

mai

l.co

m

BB

I/B

MG

FYe

sO

ral

200

Dr

Jaso

n M

athi

u M

wen

da

WH

O R

egio

nal O

ffice

for

Afr

ica

Bra

zzav

ille

Rep

ublic

o

f Co

ngo

Co

ngo

mw

end

aj@

who

.int

Ye

sO

ral

201

Dr

Sand

ram

aN

adan

Cen

tre

for E

nter

ic D

isea

ses

Nat

iona

l Ins

titut

e fo

r C

om

mun

icab

le D

isea

ses

Sout

h A

fric

asa

ndra

n@ni

cd.a

c.za

Yes

Post

er


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

202

Mrs

Kas

hmee

raN

air

Asp

en/G

SKSo

uth

Afr

ica

knai

r@as

pen

pha

rma.

com

Yes

203

Mr

Cle

men

tN

arh

Scho

ol o

f Pub

lic H

ealth

U

nive

rsity

of H

ealth

and

A

llied

Sci

ence

s

Gha

nacl

emen

ttna

rh@

gm

ail.c

om

G

SK

Yes

Post

er

204

Dr

Ab

dul

rash

eed

Nas

irU

nive

rsity

of I

lorin

Tea

chin

g

Ho

spita

l Ilo

rinN

iger

iad

raan

asir@

yaho

o.c

om

SI

IN

oPo

ster

205

Dr

Dud

uzile

Nd

wan

dw

eC

och

rane

So

uth

Afr

ica,

SA

MRC

So

uth

Afr

ica

dud

uzile

.nd

wan

dw

e@m

rc.

ac.z

a

Yes

Post

er

206

Mr

Hum

phr

ey M

wen

da

Nd

wig

aEm

bu

Leve

l V H

osp

ital

Ken

yaK

enya

ndira

ngu0

9@g

mai

l.co

m

SII

Yes

Post

er

207

Dr

Vala

ntin

eN

dze

Facu

lty o

f Med

icin

e an

d

Bio

med

ical

Sci

ence

s U

nive

rsity

of Y

aoun

de

1 C

amer

oo

n

Cam

ero

on

vale

ntin

eng

um@

yaho

o.c

om

No

Post

er

208

Dr

Mer

mo

z Th

ierr

y N

gb

anaï

e N

go

nzo

u

Ye

s

209

Ms

Jed

ida

Ng

’eth

eG

SK

Ken

ya

jed

ida.

m.n

get

he@

gsk

.co

m

Ye

s

210

Ms

Then

jiwe

Ng

om

ane

Sefa

ko M

akg

atho

Hea

lth

Scie

nces

Uni

vers

itySo

uth

Afr

ica

then

jiwen

go

man

e@g

mai

l.co

m

Ye

sPo

ster

211

Dr

Med

ard

N

go

y K

ilub

a H

op

ital P

edia

triq

ue d

e K

alem

be

Lem

be

Dem

ocr

atic

Re

pub

lic o

f the

C

ong

o

med

ard

ngo

y@ya

hoo

.co

m

Ye

sPo

ster

212

Mr

Fran

cis

Ng

oy

Mp

ung

a H

op

ital P

edia

triq

ue d

e K

alem

be

Lem

be

Dem

ocr

atic

Re

pub

lic o

f the

C

ong

o

fran

cis_

ngo

y200

7@ya

hoo

.fr

Ye

sPo

ster

213

Mr

Gas

ton

Eric

Nko

lo M

vien

aC

entr

e M

ere

et E

nfan

t de

la

Fond

atio

n C

hant

al B

iya

Cam

ero

on

eric

gas

ton7

77@

gm

ail.c

om

B

BI

Yes

Post

er

214

Mis

sTh

ob

ekile

N

kosi

Dep

artm

ent o

f Sci

ence

and

Te

chno

log

ySo

uth

Afr

ica

Tho

bek

ile.N

kosi

@d

st.g

ov.

za

Ye

s

215

Dr

Just

ice

No

nvig

non

Uni

vers

ity o

f Gha

naG

hana

jno

nvig

non@

ug.e

du.

gh

PATH

Yes

Post

er

216

Mrs

Ng

ozi

Gra

ceN

wan

kwo

Inst

itute

of C

hild

Hea

lth,

Uni

vers

ity o

f Nig

eria

Te

achi

ng H

osp

ital

Nig

eria

guz

zynw

ankw

o@

yaho

o.c

om

Yes

217

Dr

Atu

nga

Nya

chie

oIn

stitu

te o

f Prim

ate

Rese

arch

Ken

yaan

yach

ieo

@ya

hoo

.co

m

BB

IYe

sPo

ster

218

Dr

Mar

tinN

yag

aU

nive

rsity

of t

he F

ree

Stat

eSo

uth

Afr

ica

nyag

amm

@uf

s.ac

.za

BM

GF

Yes

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

219

Mr

Jam

esN

yang

aoK

EMRI

Ken

yajn

yang

ao20

00@

yaho

o.c

om

No

Post

er

220

Elay

naO

ber

man

PATH

USA

eob

erm

an@

pat

h.o

rg

Ye

s

221

Dr

John

Ben

jam

inO

chie

ngK

EMRI

Ken

yab

och

ieng

2010

@ya

hoo

.co

m

BM

GF

Yes

Post

er

222

Ms

Mer

cyO

gun

yink

aU

nive

rsity

of t

he F

ree

Stat

eSo

uth

Afr

ica

mer

cyo

g8@

gm

ail.c

om

B

BI/

B

MG

FYe

sPo

ster

223

Mr

Bill

y G

raha

mO

gw

elK

EMRI

-CG

HR

(Ken

ya

Med

ical

Res

earc

h In

stitu

te

Cen

ter f

or G

lob

al H

ealth

Re

sear

ch)

Ken

yao

gw

elb

ill@

gm

ail.c

om

No

224

Mrs

A

bio

laO

jum

u C

linto

n H

ealth

Acc

ess

Initi

ativ

eN

iger

iaao

jum

u@cl

into

nhea

lthac

-ce

ss.o

rg

N

o

225

Dr

Chi

nasa

O

kafo

r C

hukw

uem

eka

Od

umeg

wu

Oju

kwu

Uni

vers

ity T

each

ing

H

osp

ital A

mak

u A

wka

Nig

eria

dro

kafo

rchi

nasa

@g

mai

l.co

m

SII

No

Post

er

226

Dr

Ola

kunl

eO

lad

ehin

GSK

Pha

rmac

eutic

als

Nig

eria

ola

kunl

e.o

.ola

deh

in@

gsk

.co

m

Ye

s

227

Dr

Tem

itayo

Fo

loru

nso

O

low

oo

kere

GSK

Nig

eria

tem

itayo

.f.o

low

oo

kere

@g

sk.

com

Yes

228

Mr

Rich

ard

Om

ore

KEM

RIK

enya

rom

ore

@ke

mric

dc.

org

PA

THYe

sPo

ster

229

Pro

fH

este

r G

ertr

uid

aO

’Nei

llU

nive

rsity

of t

he F

ree

Stat

eSo

uth

Afr

ica

one

illhg

@uf

s.ac

.za

Ye

s

230

Dr

Um

a U

dum

a O

nwuc

hekw

aM

inis

try

of H

ealth

Mal

i

Ye

s

231

Mr

Fred

Ose

i-Sar

po

ngW

orld

Hea

lth O

rgan

izat

ion

Gha

nafo

seis

arp

ong

@w

ho.in

t

Yes

232

Dr

Mic

hel

Oth

epa

John

Sno

w, I

ncU

SAb

rian_

cast

ro@

jsi.c

om

Yes

233

Dr

John

Sam

uel

Oto

mb

a To

nda

Wo

rld H

ealth

Org

aniz

atio

nD

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

Yes

234

Dr

Nek

oye

Ots

yula

GSK

Ken

yane

koye

.n.o

tsyu

la@

gsk

.co

m

Ye

s

235

Dr

Nafi

ssat

ou

Oue

dra

og

oU

nive

rsity

of D

edo

ugo

uB

urki

na F

aso

nafis

sato

ued

rao

go

@ya

hoo

.fr

SII/

BM

GF

Yes

Post

er

236

Dr

Issa

O

ued

rao

go

Dire

cteu

r de

la P

réve

ntio

n p

ar la

Vac

cina

tion

Bur

kina

Fas

ois

saya

nn09

@ya

hoo

.fr

Ye

s

237

dr

Jane

Jum

a O

yien

go

Oum

aK

EMRI

– e

ntre

for G

lob

al

Hea

lth R

esea

rch

Ken

yao

yien

go

lusi

@g

mai

l.co

m

jjum

a@ke

mric

dc.

org

No

238

Mrs

Tin

uola

Ola

yem

iO

yinl

oye

Am

inu

Kan

o T

each

ing

H

osp

ital

Nig

eria

tinuo

yinl

oye

@ya

hoo

.co

m

N

o


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

239

Pro

fN

ico

la A

nne

Pag

eN

atio

nal I

nstit

ute

for

Co

mm

unic

able

Dis

ease

sSo

uth

Afr

ica

nico

lap

@ni

cd.a

c.za

Yes

Post

er

240

Dr

Rais

sa

Pali

Min

istr

y o

f Hea

lthC

entr

al A

fric

an

Rep

ublic

Yes

241

Gils

on

Palu

kuW

orld

Hea

lth O

rgan

izat

ion

Gab

on

Yes

242

Dr

Um

esh

Para

shar

C

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAU

ap2@

cdc.

go

v

Yes

Ora

l

243

Mr

Vija

ykum

arPa

tilSe

rum

Inst

itute

of I

ndia

Pr

ivat

e Li

mite

dIn

dia

vija

y.p

atil@

seru

min

stitu

te.

com

Yes

244

Pro

fC

lint

Pece

nka

PATH

USA

cpec

enka

@p

ath.

org

No

Ora

l

245

Mr

Phet

heg

ile E

sro

mPh

etla

Dia

rrho

eal P

atho

gen

s Re

sear

ch U

nit,

Sefa

ko

Mak

gat

ho H

ealth

Sci

ence

s U

nive

rsity

Sout

h A

fric

aPh

ethe

gile

phe

tla@

yaho

o.

com

Yes

Post

er

246

Ms

No

mce

bo

Phun

gw

ayo

Esw

atin

i Hea

lth L

abo

rato

ry

Serv

ices

eSw

atin

ice

bo

phu

ng@

gm

ail.c

om

B

MG

F Ye

sPo

ster

247

Mr

Sai

Pras

adB

hara

t Bio

tech

Inte

rnat

iona

l Lt

dIn

dia

p

rasa

dsd

@b

hara

tbio

tech

.co

m

Ye

s

248

Dr

Julia

Lili

ane

Rab

ob

aM

inis

try

of P

ublic

Hea

lth

Mad

agas

car

Mad

agas

car

lilia

ne_r

abo

ba@

yaho

o.fr

SI

IYe

sO

ral

249

Dr

Lala

ina

Rah

ajam

anan

aM

inis

try

of H

ealth

M

adag

asca

rM

adag

asca

rv_

lala

ina@

yaho

o.fr

B

MG

FYe

sPo

ster

250

Ms

Keb

aren

gR

akau

Sefa

ko M

akg

atho

Hea

lth

Scie

nces

Uni

vers

itySo

uth

Afr

ica

keb

aren

gra

kau@

gm

ail.c

om

Yes

Post

er

251

Mrs

Nts

ieni

Ram

alw

aN

atio

nal I

nstit

ute

of

Co

mm

uinc

able

Dis

ease

s (N

ICD

)

Sout

h A

fric

ant

sien

ir@ni

cd.a

c.za

No

252

Mis

sSe

bo

tsan

aR

aseb

ots

aU

nive

rsity

of t

he F

ree

Stat

eSo

uth

Afr

ica

seb

ots

anar

aseb

ots

a@g

mai

l.co

m

BM

GF

Yes

Ora

l

253

Dr

Nira

jR

athi

PATH

Ind

ia

Ye

s

254

Dr

Mar

ie C

ons

tanc

eR

azai

arim

ang

a W

orld

Hea

lth O

rgan

izat

ion

Cen

tral

Afr

ican

Re

pub

lic

Ye

s

255

Pro

fW

olfg

ang

Ren

nert

Rost

rop

ovi

ch V

ishn

eska

ya

Foun

dat

ion

USA

renn

ertw

@g

unet

.geo

rge-

tow

n.ed

u

Yes

Ora

l

256

Mr

Atif

Ria

zA

ga

khan

Uni

vers

ityPa

kist

anat

if.ria

z@ak

u.ed

u

Yes

Ora

l

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

257

Mr

Ng

oya

Eb

igui

de

Ro

ger

Qua

ntie

rO

MS

Cam

ero

on

ngo

yaro

ger

@g

mai

l.co

m

BM

GF

Yes

Post

er

258

Ms

Esm

ari

Ro

sso

uwU

nive

rsity

of P

reto

riaSo

uth

Afr

ica

u122

2592

5@tu

ks.c

o.z

a

Yes

Post

er

259

dr

Deb

asis

hSa

haG

SK V

acci

nes

Bel

giu

m

Deb

asis

h.x.

saha

@g

sk.c

om

No

260

Dr

Sab

iuSa

heed

Dur

ban

Uni

vers

ity o

f Te

chno

log

y an

d U

nive

rsity

o

f the

Fre

e St

ate

Sout

h A

fric

asa

biu

s@d

ut.a

c.za

B

BI/

B

MG

FYe

sPo

ster

261

Mrs

Kafi

lat

Salv

ado

r Oke

Sefa

ko M

akg

atho

Hea

lth

Scie

nces

Uni

vers

itySo

uth

Afr

ica

kafil

atta

i@g

mai

l.co

m

Ye

sPo

ster

262

Mr

Wic

oSa

nder

Uni

vers

ity o

f the

Fre

e St

ate

Sout

h A

fric

aw

ico

sand

er@

gm

ail.c

om

B

MG

F Ye

sPo

ster

263

Mr

Ab

ass

Ad

emo

la

Sann

iG

SKN

iger

iaab

ass.

a.sa

nni@

gsk

.co

m

Ye

s

264

Pro

f M

athu

Sa

nto

sham

John

s H

op

kins

Uni

vers

ity

U

SAM

sant

osh

am@

jhu.

edu

N

o

265

Dr

Rake

sh K

umar

Sa

roj

Cen

tre

for I

nfec

tious

D

isea

se R

esea

rch

in Z

amb

ia

(CID

RZ)

Zam

bia

rake

sh.s

aro

j@b

hu.a

c.in

No

266

Ms

Mo

llySa

uer

Inte

rnat

iona

l Vac

cine

Acc

ess

Cen

ter,

John

s H

op

kins

B

loo

mb

erg

Sch

oo

l of P

ublic

H

ealth

USA

msa

uer@

jhu.

edu

Ye

s

267

Ms

Neo

Seg

one

Uni

vers

ity o

f the

Fre

e St

ate

Sout

h A

fric

ane

oza

go

nene

@g

mai

l.co

m

BM

GF

Yes

Post

er

268

Pro

fM

apas

eka

Sehe

riSe

fako

Mak

gat

ho H

ealth

Sc

ienc

es U

nive

rsity

Sout

h A

fric

am

apas

eka.

sehe

ri@sm

u.ac

.za

BM

GF

Yes

Post

er

269

Mr

Phut

i Se

kwad

iN

atio

nal I

nstit

ute

for

Co

mm

unic

able

Dis

ease

sSo

uth

Afr

ica

phu

tis@

nicd

.ac.

za

Ye

s

270

Mr

Alh

agie

Pap

aSe

yN

atio

nal P

ublic

Hea

lth

Lab

ora

torie

s, M

inis

try

of

Hea

lth, T

he G

amb

ia

The

Gam

bia

seya

lhag

iep

apa@

yaho

o.c

om

No

271

Dr

Kei

th

Shab

aC

ong

o

Ye

s

272

Dr

Isaa

c Th

om

Shaw

aU

nive

rsity

of M

alaw

i, C

olle

ge

of M

edic

ine

Mal

awi

isha

wa@

med

col.m

w

GSK

Ye

s

273

Ms

Lora

Shim

pJo

hn S

now

, Inc

USA

lora

_shi

mp

@js

i.co

m

Ye

s

274

Dr

Ab

do

ul K

arim

Si

dib

e

USA

Yes

275

Mr

Suw

ilanj

iSi

lwam

ba

Cen

tre

for I

nfec

tious

D

isea

se R

esea

rch

in Z

amb

iaZa

mb

iasu

wi2

006@

hotm

ail.c

om

No


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

276

Mrs

Puku

taSi

mb

u El

isab

eth

Inst

itut N

atio

nal d

e Re

cher

che

Bio

med

ical

D

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

elis

epuk

uta@

gm

ail.c

om

Yes

Post

er

277

Mrs

Cel

iwe

Sim

elan

e M

inis

try

of H

ealth

, eSw

atin

i eS

wat

ini

celiw

esim

elan

e@g

mai

l.co

m

Ye

s

278

Mr

Mic

helo

Sim

uyan

di

Cen

tre

for I

nfec

tious

D

isea

se R

esea

rch

in Z

amb

iaZa

mb

iaM

iche

lo.S

imuy

and

i@ci

drz

.o

rg

Ye

sPo

ster

279

Ms

Julia

Si

mw

aka

Min

istr

y o

f Hea

lthZa

mb

iaju

liach

ibum

bya

@g

mai

l.co

m

BM

GF

Yes

280

Dr

Ved

Sing

hG

SK B

iolo

gic

als

Bel

giu

mve

d.s

.sin

gh@

gsk

.co

m

Ye

sPo

ster

281

Dr

Seyd

ou

Siss

oko

Ye

s

282

MR

Venk

atra

man

Siva

ram

akris

hnan

Bha

rat B

iote

ch In

tern

atio

nal

Ltd

Ind

iave

nkat

ram

an20

65@

bha

ratb

i-o

tech

.co

m

Ye

s

283

Ms

Whi

tney

Will

iam

sSk

ow

rons

kiC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAw

sko

wro

nski

@cd

cfo

und

a-tio

n.o

rg

Ye

s

284

Dr

Ken

dal

lSm

itC

hris

Han

i Bar

agw

anat

h H

osp

ital

Sout

h A

fric

akk

smit3

01@

gm

ail.c

om

Yes

285

Ms

Arle

neSm

ith

SAM

RCSo

uth

Afr

ica

arle

ne.s

mith

@m

rc.a

c.za

B

MG

F Ye

s

286

Dr

Aris

tide

Ro

ch

Soss

ou

Wo

rld H

ealth

Org

aniz

atio

nB

enin

Yes

287

Dr

Mo

ufid

ath

Om

onw

oun

i Re

mi S

tar

Soun

kere

So

roM

inis

try

of H

ealth

and

Sa

nita

ryC

ôte

d’Iv

oire

s.m

oufi

dat

h@ya

hoo

.fr

WH

OYe

sPo

ster

288

Dr

Dun

can

Stee

leB

MG

HU

SAd

unca

n.st

eele

@g

ates

foun

da-

tion.

org

Yes

289

Dr

Am

ySt

ryd

om

Uni

vers

ity o

f the

Fre

e St

ate

Sout

h A

fric

ast

ryd

om

a@uf

s.ac

.za

Ye

s

290

Dr

Nso

fwa

Sukw

aC

entr

e fo

r Inf

ectio

us

Dis

ease

Res

earc

h in

Zam

bia

Zam

bia

nso

fwa.

sukw

a@ci

drz

.org

B

MG

F Ye

sPo

ster

291

Dr

Shaz

ia

Sulta

naA

ga

khan

Uni

vers

ityPa

kist

ansh

azia

.sul

tana

@ak

u.ed

u

Yes

292

Dr

Bec

kie

Tag

bo

Inst

itute

of C

hild

Hea

lth

Uni

vers

ity o

f Nig

eria

Te

achi

ng H

osp

ital

Nig

eria

tag

bo

bec

kie@

gm

ail.c

om

W

HO

No

Post

er

293

Dr

And

re

Ta

gne

Sad

oG

SKC

ôte

d’Iv

oire

and

re.x

.tag

ne@

gsk

.co

m

Ye

s

294

Dr

Jacq

uelin

eTa

teC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAjq

t8@

cdc.

go

v

Yes

295

Pro

fM

aure

enTa

ylo

rN

HLS

/TA

D &

Uni

vers

ity o

f Pr

eto

riaSo

uth

Afr

ica

mau

reen

.tay

lor@

up.a

c.za

Yes

296

Mr

Emm

anue

l Yo

hana

Tess

uaM

inis

try

of H

ealth

-Tan

zani

aTa

nzan

ia

N

o

AN

NEX

URE

A: 1

2th

ARS

LIS

T O

F D

ELEG

ATE

S (C

ON

TIN

UED

)


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

297

Dr

Tush

ar

Tew

ari

PATH

Ind

iatt

ewar

i@p

ath.

org

Yes

298

Mis

sEs

ther

Thau

loM

alaw

i Liv

erp

oo

l Wel

lco

me

Trus

t Clin

ical

Res

earc

h Pr

og

ram

me

Mal

awi

etha

ulo

@m

lw.m

w

SII

Yes

Post

er

299

Mr

Luan

Thea

rtN

ort

h W

est U

nive

rsity

Sout

h A

fric

alu

an.t

hear

t@g

mai

l.co

m

BM

GF

Yes

Post

er

300

Dr

Nic

ola

sTh

eop

old

BM

GF

USA

Nic

ola

s.th

eop

old

@g

ates

-fo

und

atio

n.o

rg

Ye

s

301

Dr

Juno

Tho

mas

Nat

iona

l Ins

titut

e fo

r C

om

mun

icab

le D

isea

ses

Sout

h A

fric

aju

not@

nicd

.ac.

za

Ye

s

302

Dr

Alfr

ed T

hutlo

aSA

MRC

Sout

h A

fric

aal

fred

.thu

tloa@

mrc

.ac.

za

BM

GF

Yes

303

dr

Sano

go

Tia

ria M

amad

ou

CVD

-Mal

iM

ali

tiaria

sano

go

@g

mai

l.co

m

N

o

304

Mr

Lop

iso

Tiro

reA

dd

is A

bab

a U

nive

rsity

Ethi

op

ialo

ped

essa

leg

n@g

mai

l.co

m

SII/

BM

GF

No

Post

er

305

Dia

kalia

Trao

reM

inis

try

of P

ublic

Hea

lthM

ali

dia

kalia

_tra

ore

@ya

hoo

.fr

Ye

s

306

Dr

Enyo

nam

Tso

leny

anu

Min

istr

y o

f Hea

lth in

To

go

Tog

ots

ole

nyan

u_en

yona

m@

yaho

o.fr

Yes

Post

er

307

Ms.

Vero

niq

ueTu

biji

nga

Bak

asha

la

Ho

pita

l Ped

iatr

ique

de

Kal

emb

e Le

mb

eD

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

tub

ijing

a@ya

hoo

.fr

N

oPo

ster

308

Dr

Savi

Che

tty

Tuls

eeSC

T C

ons

ultin

gSo

uth

Afr

ica

savi

.sct

@m

web

.co

.za

Ye

s

309

Dr

Kris

hna

Mo

han

Vad

revu

Bha

rat B

iote

ch In

tern

atio

nal

Ltd

Ind

iakm

oha

n@b

hara

tbio

tech

.co

m

Ye

s

310

Pro

f A

lbie

Van

Dijk

No

rth

Wes

t Uni

vers

itySo

uth

Afr

ica

alb

ie.v

and

ijk@

nwu.

ac.z

a B

MG

FYe

s

311

Mr

Dan

iel

Vela

sque

zC

ente

rs fo

r Dis

ease

Co

ntro

l an

d P

reve

ntio

nU

SAiq

m6@

cdc.

go

v

Yes

Post

er

312

Mr

Mar

tinV

isse

rN

ort

h W

est U

nive

rsity

Sout

h A

fric

am

artin

viss

er75

@g

mai

l.co

m

BM

GF

Yes

Post

er

313

Ms

Leo

cad

ie

Voum

by

C

ong

o

Ye

s

314

Mr

Am

inu

Wad

a K

ura

Nat

iona

l Bio

tech

nolo

gy

Dev

elo

pm

ent A

gen

cy A

buj

aN

iger

iaw

adak

ura@

gm

ail.c

om

SI

IN

oPo

ster

315

Dr

Erne

stW

and

era

Ap

ond

iK

EMRI

K

enya

eaw

and

era@

gm

ail.c

om

G

SKYe

sO

ral

316

Dr

Go

itom

W

eld

egeb

riel

Wo

rld H

ealth

Org

aniz

atio

nZi

mb

abw

e

Ye

s

317

Dr

Tap

sob

aW

end

lam

ita T

ous

sain

tC

entr

e H

osp

italie

r U

nive

rsita

ire P

edia

triq

ue

Cha

rles

de

Gau

lle d

e O

uag

ado

ugo

u

Bur

kina

Fas

ota

p_t

ous

sain

t@ya

hoo

.fr

WH

OYe

sPo

ster


No.

Title

Firs

t Nam

eLa

st N

ame

Org

anisa

tion

Coun

tryEm

ail

Spon

sor

Atte

nded

Pres

enta

tion

type

318

Pro

fFr

edric

k W

ere

Pro

fess

or o

f Ped

iatr

ics

&

Chi

ld H

ealth

, Uni

vers

ity o

f N

airo

bi

Ken

yafr

ednw

ere@

gm

ail.c

om

G

SK

Yes

319

Dr

Rith

aW

illilo

Wo

rld H

ealth

Org

aniz

atio

nTa

nzan

iaw

illilo

r@w

ho.in

t B

MG

FYe

s

320

Mis

sA

ben

a A

hwia

nfo

a Ya

wso

nYa

wso

nB

hara

t Bio

tech

Inte

rnat

iona

l Lt

dG

hana

aben

a19@

bha

ratb

iote

ch.

com

Yes

321

Dr

Flo

re S

and

rine

Zab

aB

acte

riolo

gy

Viro

log

y La

bo

rato

ry o

f Tea

chin

g

Ho

spita

l of Y

op

oug

on

Cô

te d

’Ivo

iresa

ndyz

aba@

yaho

o.fr

W

HO

Yes

Post

er

322

Mr

Jere

mia

h O

mar

i Za

blo

nZa

blo

nK

enya

tta

Nat

iona

l Ho

spita

lK

enya

Jzab

lon2

000@

yaho

o.c

om

Yes

323

Dr

Co

nyan

bya

lgo

Ach

ille

ZAB

RE

Ges

tionn

aire

de

do

nnée

à

la D

irect

ion

de

la P

réve

ntio

n p

ar la

Vac

cina

tion

Bur

kina

Fas

oza

bre

cac@

yaho

o.fr

Yes

324

Dr

Jag

dis

hZa

de

Seru

m In

stitu

te o

f Ind

ia

Priv

ate

Lim

ited

Ind

iaja

gd

ish.

zad

e@se

rum

inst

i-tu

te.c

om

Yes

325

Dr

Mam

anZa

neid

ou

MSP

Nig

erN

iger

mza

neid

ou@

yaho

o.fr

No

326

Dr

Mic

hael

M

ol

Hel

lo D

oct

or

Sout

h A

fric

a

Ye

s

327

Dr

Ban

koto

Mua

luke

Ze

phy

rine

D

emo

crat

ic

Rep

ublic

of t

he

Co

ngo

Yes

SAM

RC E

vent

s Man

agem

ent s

taff

M

sK

efilo

e M

asem

ola

SAM

RC S

out

h A

fric

a K

efilo

e.m

asem

ola

@m

rc.

ac.z

a

Yes

M

sM

and

y Sa

lom

o

SAM

RC S

out

h A

fric

a m

and

y.sa

lom

o@

mrc

.ac.

za

Y

es

M

rD

eon

Salo

mo

SA

MRC

So

uth

Afr

ica

deo

n.sa

lom

o@

mrc

.ac.

za

Y

es

M

sVe

roni

ca P

iena

ar

SAM

RC S

out

h A

fric

a v

ero

nica

.pie

naar

@m

rc.a

c.za

Yes

M

rRo

ber

t Gan

esh

SA

MRC

So

uth

Afr

ica

rob

ert.

gan

esh@

mrc

.ac.

za

Y

es

M

sM

iche

lle F

red

eric

ks

SAM

RC S

out

h A

fric

a e

vent

2@m

rc.a

c.za

Yes


ANNEXURE B: LIST OF DELEGATES BY ORGANISATION

Institution No. of delegates

Abuth Zaria 1

Aga khan University 2

Ahmadu Bello University Teaching Hospital, Shika Zaria 1

Albert Royer Paediatric Hospital Laboratory 1

Amsterdam Institute for Global Health and Development, University of Amsterdam 1

Anatech 1

Aspen/GSK 1

Bacteriology Virology Laboratory of Teaching Hospital of Yopougon 1

Bharat Biotech International Ltd 7

Biovac 2

BMGF 3

Caritas Baby Hospital 1

Center for Vaccine Development 1

Centers for Disease Control and Prevention 13

Centre for Enteric Diseases National Institute for Communicable Diseases 1

Centre for Infectious Disease Research, Zambia 7

Centre Hospitalier Universitaire Pediatrique Charles de Gaulle de Ouagadougou 1

Centre Mere et Enfant de la Fondation Chantal Biya 1

Chris Hani Baragwanath Hospital 1

Clinton Health Access Initiative 1

Cochrane South Africa, SAMRC 1

Department of Science and Technology, South Africa 2

Department of the Ghana Health Service 1

Diarrhoeal Pathogens Research Unit, Sefako Makgatho Health Sciences University 1

Directeur de la Prévention par la Vaccination 1

Directeur Général Point focal du Laboratoire de référence Rotavirus 1

Dodowa Health Research Centre 1

Durban University of Technology and University of the Free State 1

Embu Level V Hospital, Kenya 1

Emory University 1

Eswatini Health Laboratory Services 1

Ethiopian Public Health Institute 1

European Developing Countries Clinical Trials Partnership 1

Expanded Program on Immunization 1

Federal Medical Center Asaba 1

Federal Ministry of Health 1

Fogarty International Center, National Institutes of Health 1

Futurehands 1

GAVI 1



Gestionnaire de donnée à la Direction de la Prévention par la Vaccination 1

Ghana Health Service 1

GSK 10

GSK Biologicals 2

GSK Pharmaceuticals 2

GSK Vaccines, Belgium 1

Hello Doctor 1

Higher Institute of Medical Techniques of Lubumbashi 1

Hopital Pediatrique de Kalembe Lembe 2

Immunization programme 1

Imperial College London 1

Institut National de Recherche Biomedical 1

Institut Pasteur de Bangui 2

Institute of Child Health, University of Nigeria Teaching Hospital 1

Institute of Primate Research 3

Instituto Nacional de Saúde (INS), Mozambique 2

International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health 1

John Snow, Inc 4

Johns Hopkins University Bloomberg School of Public Health 1

KEMRI 6

Kenya Institute of Primate Research 1

Kenyatta National Hospital 1

Kigali University Teaching Hospital 1

Komfo Anokye Teaching Hospital (KATH) 1

Laboratory 1

LSHTM 1

Malawi Liverpool Wellcome Trust Clinical Research Programme 5

Mbagathi County Hospital 1

Medical Research Council Unit The Gambia at the London School of Hygiene Tropical Medicine 1

Minister of Health. Teaching hospital of Yopougon Abidjan . Department of pediatric surgery 1

Ministry of Health 6

Ministry of Health and Child Care 1

Ministry of Health and Sanitary 1

Ministry of Health, Togo 1

Ministry of Health, Madagascar 1

Ministry of Health, Palestine 1

Ministry of Health, Uganda 1

Ministry of Health, eSwatini 1

Ministry of Health, Zanzibar 1

Ministry of Public Health 1

Ministry of Public Health Madagascar 1



MoH Benin 1

National Health Institute 1

National Health Laboratory 1

National Institute for Communicable Diseases 3

National Institute for Communicable Diseases & University of the Witwatersrand School of Public Health 1

National Institute of Health 1

National Institute of Health Mozambique 2

National Laboratory of Public Health, Benin 1

National Primary Health Care Development Agency 1

NHLS/TAD & University of Pretoria 1

NICD 1

Nigeria Immunization Technical Advisory Group (NGI-TAG) 1

Noguchi Memorial Institute for Medical Research, University of Ghana 5

North West University 5

North West University Potchefstroom Biochemistry dep. 1

OMS 1

Palestinian Ministry of Health 1

PATH 11

Pédiatre, coordonnateur du site Rota de l’hôpital pédiatrique 1

Professor of Pediatrics & Child Health, University of Nairobi 1

Ravin/JSI 1

Research Consultant 2

Respiratory and Meningeal Pathogens Research Unit, Wits 1

Rostropovich Vishneskaya Foundation 1

SAMRC 4

School of Public Health University of Health and Allied Sciences 1

SCT Consulting 1

Sefako Makgatho Health Sciences University 8

Self employee 1

Serum Institute of India Private Limited 5

South African Vaccination and Immunization Center (SAVIC) 1

ANNEXURE B: LIST OF DELEGATES BY ORGANISATION



Student Technical University 1

Suru Lere Hospital 1

The Biovac Institute 1

The Technical University of Kenya 1

Uganda Virus Research Institute 1

UNICEF Supply Division 1

University Center of Cocody and President of the Association of African Pediatric Societies 1

University Felix Houphouet Boigny Abidjan 1

University Hospital Sahloul 1

University Mohammed V 1

University of Benin Teaching Hospital 1

University of Dedougou 1

University of Dodoma 1

University of Ghana 1

University of Ilorin Teaching Hospital 1

University of Liverpool 1

University of Malawi, College of Medicine 2

University of Maryland School of Medicine 1

University of Pretoria 3

University of the Free State 10

University of the Free State Next Generation Sequencing Unit 1

University of the Witwatersrand 2

University of Zimbabwe 2

University Ouaga1Pr Joseph KI ZEBO 1

University Teaching Hospitals 1

WHO Country office 1

WHO Regional Office for Africa Brazzaville Republic of Congo 1

WHO supported Rotavirus Sentinel Site Enugu Nigeria 1

Wits Reproductive Health and HIV Institute (WITS RHI) 1

WHO 14

Unknown 8


ANNEXURE C: 12TH ARS - ABSTRACT REVIEW FORM

Static Questions

Abstract Number: (This information gets generated from the abstract form)Abstract Title: (This information gets generated from the abstract form)Abstract Content: (This information gets generated from the abstract form)Do you have a conflict of interest: YES/NO (Compulsory question to be answered by reviewer)Is this topic/abstract in your area of expertise: YES/NO (Compulsory question to be answered by reviewer)Please provide comments to motivate your score and recommendation: (Question to be answered by reviewer – not compulsory)

Dynamic Questions

Abstract assessment:Provide an overall rating for each set of review questions listed using the following scale:

1 = Poor/incomplete 2 = Fair 3 = Good 4 = Very good 5 = Excellent

Scoreout of 5

Relevance to the 12th ARS 2019 Symposium: “A decade of rotavirus vaccination in Africa”• Does the abstract address the ARS 2019 Symposium key theme?• Is it likely that the presentation will be of interest to the Symposium participants?

1 2 3 4 51 2 3 4 5

Clarity of purpose and objectives of the study/programme/policy:• Are the objectives of the study clear and well presented?• Is a short summary/synopsis of the issue(s) presented?

1 2 3 4 51 2 3 4 5

Appropriateness of the methodology and design:• Is the data analysis and interpretation appropriate?• Is the methodology used appropriately?

1 2 3 4 51 2 3 4 5

Significance of the study/programme/policy:• Are the study/programme/policy findings significant?• Are the conclusions well supported and appropriate?• Is the study/programme/policy innovative and original? Does it provide new insights in this area of

research and innovation?

1 2 3 4 51 2 3 4 5

1 2 3 4 5

Contribution of the study:• Contributes to new knowledge/new/upgraded service delivery/new techniques or practice • Provides recommendations for future studies• Based in LMICs/resource poor settings

1 2 3 4 51 2 3 4 51 2 3 4 5

Reviewer recommendations:

Oral presentation Yes No

Poster presentation Yes No

Panel presentation Yes No

In this space the abstract text will appear (please note that only the abstract title and text will be visible. Names of author(s) and co-authors as well as their affiliations will not be included.)


ANNEXURE D: 12TH ARS PROGRAMME

AFRICAN ROTAVIRUS

12TH

A DECADE OF ROTAVIRUS VACCINATION IN AFRICASAVING LIVES AND CHANGING

THE FACE OF DIARRHOEAL DISEASE

EMPERORS PALACE JOHANNESBURG 30 JULY – 1 AUGUST 2019


TUESDAY, 30 JULY 2019

08:00 – 09:00 Registration & Tea/Coffee

09:00 – 10:30 SESSION 1: OPENING CEREMONY

Moderators: Jeffrey Mphahlele, SAMRC and Jason Mwenda, WHO AFRO

Welcome remarks – Symposium Chair - Jeffrey Mphahlele, SAMRC

Remarks – Umesh Parashar, CDC; Duncan Steele, BMGF; Jason Mwenda, WHO AFRO and Deborah Atherly, PATH.

Third Professor Duncan Steele Lecture Series – George Armah, Noguchi Institute of Medical Research/University of Ghana

10:30 – 11:00 REFRESHMENTS & POSTER PRESENTATIONS

11:00 – 13:00 SESSION 2: ROTAVIRUS BURDEN OF DISEASE AND EPIDEMIOLOGY IN AFRICA

Moderators: Adam Cohen, WHO and Nicola Page, NICD

11:00 - 11:25 Fred Were, University of Nairobi - Integrated control and prevention of diarrhea in children in Africa

11:25 - 11:50 Jacqueline Tate, CDC, USA - Global Rotavirus disease burden

11:50 – 12:10 Aybuke Koyuncu, Centre for Infectious Diseases Research (CIDRZ), Zambia – Nutritional status and the prevalence of rotavirus diarrhea among children in Zambia

12:10 – 12:30 Jason Mwenda, WHO AFRO, Congo – Progress of the rotavirus vaccine introduction and impact on rotavirus hospitalizations among children under 5 in Africa

12:30 – 13:00 Discussion

13:00 – 14:00 LUNCH & POSTER PRESENTATION

14:00 – 15:30 SESSION 3: UNDERSTANDING DIARRHEAL DISEASE AND ENTERIC PATHOGENS IN AFRICA

Moderators: Jacqueline Tate, CDC and Roma Chilengi, CIDRZ

14:00 - 14:25 Adam Cohen, WHO Switzerland - Etiology of diarrhea in hospitalized children under 5 years of age in Africa: Preliminary results from the first 2 years of the GPDSN, 2017-2018

14:25 - 14:45 Karen Kotloff, University of Maryland, USA – Etiology and adverse clinical consequences of moderate-to-severe diarrhea among children under 5 in three sub-Saharan African countries post-rotavirus vaccine introduction


14:45 - 15:05 Caroline Chisenga, Centre of Infectious Disease Research (CIDRZ), Zambia - Aetiology of diarrhoea in children under five in Zambia detected using luminex xTAG gastrointestinal pathogen panel

15:05 - 15:25 Mapaseka Seheri, Sefako Makgatho Health Sciences University, South Africa - Enteric pathogens associated with diarrhoeal outbreak in Botswana and Eswatini in 2018

15:25 - 15:30 Discussion – highlighting some specific posters in this section

15:30 – 16:00 REFRESHMENTS & POSTER PRESENTATION

16:00 – 17:30 SESSION 4: MOLECULAR EPIDEMIOLOGY AND ROTAVIRUS STRAIN DIVERSITY IN AFRICA

Moderators: Mapaseka Seheri, Sefako Makgatho Health Sciences University and Martin Nyaga, University of the Free State

16:00 - 16:12 Chantal Agbemabiese, Noguchi Memorial Institute for Medical Research/University of Ghana – Interspecies transmission of rotaviruses and its evolutionary implication: A view from Africa

16:12 – 16:24 Sebotsana Rasebotsa, University of the Free State, South Africa - Analysis of G1P[8] whole genome constellations identifies a vaccine-derived strain in Rwanda

16:24 - 16:36 Julia Liliane Raboba, Ministry of Public Health, Madagascar - Diversity of rotavirus genotypes in Madagascar before and after rotavirus vaccine introduction

16:36 – 16:48 Ngah Carine Enjeh, University of Yaoundé, Cameroon - Identification of rotavirus strains circulating in the south west region of Cameroon after vaccine introduction

16:48 – 17:00 Khuzwayo Jere, Malawi Liverpool Welcome Trust Clinical Research Programme - Evaluation of rotavirus vaccine effectiveness against G1 and G2 strains possessing a DS-1-like genetic backbone In Malawian infants

17:00 – 17:12 Simone Salvador Boene, National Institute of Health, Mozambique - Whole genome characterization of porcine rotavirus a collected in southern Mozambique, reveals G9P[13] and G4P[6] strains with a WA-like backbone

17:12 – 17:30 Discussion – highlighting specific poster presentations

17:30-18:00 POSTER PRESENTATIONS

18:30 - 22:00 SYMPOSIUM DINNER - RED SHED AT EMPERORS PALACE

WEDNESDAY 31 JULY 2019

08:30 – 11:00 SESSION 5: ROTAVIRUS VACCINE IMPLEMENTATION IN AFRICA

Moderators: Umesh Parashar, CDC and George Armah, NIMR/University of Ghana

08:30 – 08:55 Michelle Groome, University of the Witwatersrand, South Africa - Intussusception and rotavirus vaccines – An overview of global and African data


08:55 – 09:20 Andy Clark, London School of Hygiene and Tropical Medicine, UK - Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low- and middle-income countries: evaluation of current and alternative schedules

09:20 – 09:40 Sozinho Acacio, Research Center in Health of Manhica, Mozambique - Impact of rotavirus vaccination in children less than 5 years of age in rural southern Mozambique

09:40 – 10:00 Sammy Khagayi, Kenya Medical Research Institute - Effectiveness of a monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children

10:00 – 10:20 Atif Riaz, Aga Khan University, Pakistan - Impact assessment of rotavirus vaccine introduction in Pakistan’s routine immunization program

10 :20 – 11 :00 Discussion – highlighting some specific posters in this section

11:00 – 11:30 REFRESHMENTS & POSTER PRESENTATION

11:30 – 13:30 SESSION 6: ROTAVIRUS VACCINE DEVELOPMENT UPDATES

Moderators: Carl Kirkwood, BMGF and Michelle Groome, Wits University

11:30 – 11:45 Umesh Parashar, CDC, USA - An overview of the current and future rotavirus vaccines

11:45 – 12:05 Ved Singh and Bernd Benninghoff, GSK, Belgium - Success story of human rotavirus vaccines in Africa and beyond! Lessons learned

12:05 – 12:25 Sai D. Prasad, Bharat, India - ROTAVAC® and ROTAVAC® 5D – Product development and programmatic implementation

12:25 – 12:45 A Desai Sajjad, Serum Institute, India - Updates on Rotasiil rotavirus vaccine

12:45 – 13:10 Lee Fairlie, University of the Witwatersrand, South Africa – Safety and immunogenicity of P2-VP8 subunit vaccine

13 :10 – 13 :30 Discussion

13:30 – 15:00 LUNCH & POSTER PRESENTATION

15:00 - 17:00 SESSION 7: CELEBRATION OF THE AFRICAN ROTAVIRUS NETWORK 20TH ANNIVERSARY AND THE SOUTH AFRICAN MEDICAL RESEARCH COUNCIL (SAMRC) 50TH ANNIVERSARY

Theme: A decade of rotavirus vaccination in AfricaHighlights of the achievements of both the African Rotavirus Network and collaboration with the SAMRC

Moderator: Dr Michael Mol

Panellists to include South African Department of Health, BMGF, WHO, GAVI, UNICEF, South African Medical Research Council & African Rotavirus Network

17:00 - 18:00 NETWORKING OPPORTUNITIES


THURSDAY 1 AUGUST 2019

08:30 – 10:30 SESSION 8: SCIENTIFIC ADVANCES IN ROTAVIRUS RESEARCH IN AFRICA

Moderators: Khuzwayo Jere, Malawi LWTCRP and Roger Glass, NIH

08:30 – 08:50 Peter Mwangi, University of the Free State, South Africa – Molecular characterization of rotavirus strains using whole genome sequencing reveals unique changespost-rotavirus vaccine introduction in Zambia

08:50 – 09:10 Theresa Resch, CDC – Increased expression of pro- inflammatory markers in children with intussusception in South Africa

09:10 – 09:30 Chikondi Malamba, Malawi Liverpool Welcome Trust Clinical Research Programme (Malawi LWTCRP) – Rotavirus vaccine shedding is associated with increased frequency of circulating T-follicular helper and T-helper cells in Malawian infants

09:30 – 09:50 Ernest Wandera Apondi, Kenya Medical Research Institute – Genomic characterization of uncommon human G3P[6] rotavirus strains that emerged in Kenya after rotavirus vaccination

09:50 – 10:10 Marno Huysers, North West University, Potchefstroom, South Africa – Local implementation and optimization of plasmid-only rotavirus reverse genetics

10:10 – 10:30 Discussion – Questions and Answer


11:00 - 12:55 SESSION 9: THE ECONOMIC AND PUBLIC HEALTH IMPACT OF ROTAVIRUS VACCINES IN AFRICA

Moderators: Deborah Atherly, PATH and Justice Nonvignon, University of Ghana

11:00 - 11:10 Deborah Atherly, PATH, USA - Short opening statement of economic evaluations in Africa

11:10 - 11:35 Gitte Giersing, WHO, Switzerland – 'How can the TSE approach inform the public health value proposition for next generation rotavirus vaccines?

11:35 - 11:55 John Anderson, Research Consultant, USA – Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost effectiveness of vaccination in Nigeria

11:55 - 12:15 Palwasha Anwari, Independent, Afghanistan – Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan

12:15 - 12:35 Frederic Debellut, PATH, Switzerland - Impact and cost-effectiveness of rotavirus vaccination in Palestine

12:35 - 12:55 Clint Pecenka, PATH, USA – Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana and Malawi: A comparison across three WHO pre-qualified vaccines

12:55 – 14:00 LUNCH & POSTER PRESENTATIONS


14:00 – 15:30 SESSION 10: VACCINE POLICY AND DECISION-MAKING IN AFRICA

Moderators: Duncan Steele, BMGF and Fred Were, University of Nairobi

14:00 - 14:25 Thomas Cherian, Independent, India - Introduction of ROTAVAC and RotaSIIL vaccines in India: Lessons, challenges and way forward for Africa

14:25 - 14:45 Veronica Denti, GAVI, Switzerland – Navigating the unprecedented range of rotavirus vaccine options now available to Gavi-supported countries

14:45 – 15:00 Wolfgang Rennart, Rostropovich Vishneskaya Foundation, USA – Introducing rotavirus vaccine to LMICs: Establishing sustainable immunization program in Palestine using ROTAVAC

15:00 - 15:20 Shingai Machingaidze, EDCTP, South Africa – Strengthening South-North collaboration for research on diarrheal diseases

15:20 – 15:30 Discussion


16:00 – 16:30 CLOSING CEREMONY

Moderators: Jeffrey Mphahlele, SAMRC and Madeleine Amorissani-Folquet, CHU Cocody, Abidjan, Côte d’Ivoire

Key highlights of symposium/Joint statement: Jeffrey Mphahlele, SAMRC

Announcement of the host country of the 13th African Rotavirus SymposiumDuncan Steele, BMGF and Jason Mwenda, WHO AFRO

Closing remarksDuncan Steele, BMGF

ANNEXURE E:CONSOLIDATED INCOME AND EXPENDITURE REPORT FOR THE EVENT 30 JULY TO 01 AUGUST 2019

R

INCOME 5,409,449.21

BHARAT Biotech 345,047.50

Bill & Melinda Gates Foundation (BMGF) 3,664,486.14

Glaxosmithkline (GSK) 627,408.00

PATH 355,000.00

South African Medical Research Council (SAMRC) 50,000.00

Serum Institute of India (SERUM) 367,507.57

EXPENDITURE (3,416,421.33)

1. Funders expenses (3,287,439.89)

BHARAT Biotech (333,743.62)

Bill & Melinda Gates Foundation (BMGF) (1,720,468.21)

Glaxosmithkline (GSK) (506,848.73)

PATH (347,264.96)

South African Medical Research Council (SAMRC) (50,000.00)

Serum Institute of India (SERUM) (329,114.37)

2. Funders refunds (128,981.44)

PATH (Refund paid) (8,422.17)

Glaxosmithkline (GSK) (Refund to be paid) (120,559.27)

TOTAL SURPLUS 1,993,027.88

The income statement is a true reflection of the income and expenditure as per the SAMRC’s financial records.

REPORT ON THE 12TH AFRICAN ROTAVIRUS SYMPOSIUM 2019 41

MANDY SALOMOOffice ManagerSAMRC Event Management OfficeDate: 27 March 2020

PHILIP du PLESSISDivisional ManagerProject & Management Accounting OfficeDate: 27 March 2020

Date post:	23-Jan-2023
Category:	Documents
Upload:	khangminh22
View:	0 times
Download:	0 times

12TH AFRICAN ROTAVIRUS

Documents